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Iron deficiency is an important public health problem that is estimated to affect 
over one-half the world population. Improving the nutritional quality of staple food 
crops such as maize, by developing varieties with high bioavailable iron represents a 
sustainable and cost effective approach to alleviating iron malnutrition. The aim of our 
study was to use a Caco-2 cell / quantitative trait loci (QTL) / and poultry approach to 
discover the genes that influence maize grain iron concentration and amount of 
bioavailable iron. After several breeding cycles guided by measurements of iron 
bioavailability with the Caco-2 cell model, we identified two maize lines with 
identical grain iron concentration (20 µg/g), but one line contained double the amount 
of bioavailable iron (p < 0.001). Three QTL were found to influence the 
bioavailability of iron in the two maize lines. Measurement of iron status in a poultry 
model confirmed the results of the Caco-2 cell model. Some of the lines screened 
using the Caco-2 cell / QTL / and poultry approach have been grown at multiple 
locations and data show a strong genotype × environment (GxE) interaction. We 
conclude that conventional breeding can significantly improve iron bioavailability in 
maize grain and that the GxE effect plays a major role in iron bioavailability. Human 
feeding trials should be conducted to determine the efficacy
 
of consuming the high 
bioavailable iron maize.  
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  CHAPTER 1 
INTRODUCTION 
 
The problem 
Iron deficiency (ID), which affects more than two billion people globally, is by 
far the most widespread micronutrient deficiency in the world. Its prevalence in 
women of childbearing age and young children, especially those in developing 
countries, is high and often due to multifactorial causation (Zimmermann & Hurrell, 
2007; World Health Organization [WHO], 2001). Iron deficiency develops after iron 
stores in the liver, bone marrow, and spleen are depleted and erythropoiesis is 
compromised or diminished. If not corrected, the resulting depletion of storage iron 
and reduction in transport iron typically lead to a reduction in hemoglobin 
concentration, which is an indicator of iron deficiency anemia (IDA; see Figure 1.1, 
Beard, Dawson & Piñero, 1996).  
Nutritional IDA often results when an individual‘s dietary iron supply cannot 
meet the physiological requirements for the synthesis of functional iron compounds 
such as hemoglobin. Such a condition can be caused by either low levels of iron intake 
or poor bioavailability of dietary iron, particularly in populations that consume 
monotonous plant-based diets with little or no intake of iron-rich foods such as liver, 
pork, or other meat products. Non-nutritional factors such as malaria, HIV infection, 
and other chronic diseases are also associated with anemia. Helminth infections also 
contribute to anemia, principally by increasing iron losses and further exacerbating 
any existing iron deficiency (Underwood, 2001; Allen & Casterline-Sabel, 2001). 
The major consequences of IDA include impaired growth, retarded 
psychomotor development and poor cognitive development in children, a damaged 
immune mechanism associated with increased morbidity and mortality rates in all age 
2 
 
groups, and reduced work capacity in adults (WHO, 2001; Neumann, Gewa & Bwibo, 
2004).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Depletion of body iron resulting in iron deficiency and anemia 
 
This overview chapter will briefly discuss the main strategies for correcting 
ID, focus attention on why biofortification is needed, highlight aspects of iron 
homeostasis in the plant and animal kingdom, and lastly consider our research 
interests and objectives. 
 
Strategies for addressing nutritional iron deficiency 
Traditionally, three main strategies for correcting ID have been employed in 
various populations. These include: 
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1. Dietary diversification and modification: The monotonous plant diet, and 
low iron absorption from such diets have been identified as a major cause of 
nutritional iron deficiency in many populations. The goal of dietary diversification and 
modification is thus to improve dietary iron intake and bioavailability. This strategy 
promotes intake of foods low in iron inhibitors and the use of iron-rich foods like 
meats in conjunction with other foods such as orange juice or lime juice that are rich 
in ascorbic acid, which is known to enhance iron bioavailability. Properly designed 
dietary modification also encourages reduced consumption during meals of phenolic-
rich foods or beverages such as teas and coffee that are known to inhibit iron 
bioavailability (Ruel & Levin, 2002; Hallberg & Rossander, 1982a, 1984). Although 
dietary diversification and modification is an ideal approach, it is difficult to achieve 
the desired results without a strong educational component. It is difficult, that is, to 
change traditional dietary behaviors or preferences and doing so may be costly in 
many poor resource areas where meat is expensive (Zimmermann & Hurrell, 2007). 
2. Iron supplementation: Iron supplementation is a public health intervention 
targeted at groups at high risk of developing IDA, providing high doses of iron in the 
form of tablets for adults or drops for children. Supplementation programs can be cost 
effective, but constraints such poor infrastructure, poor public health management 
policies, and ineffective institutions may diminish their effectiveness and outreach 
success, particularly in developing countries. Poor compliance at the individual level 
(as a result of side effects such as nausea and stomach pain) may also limit the success 
of supplementation programs. In addition, recent studies show that untargeted iron 
supplementation in children living in malaria-endemic regions may carry increased 
risk of morbidity and mortality (Zimmermann & Hurrell, 2007; Sazawal et al., 2006). 
3. Iron fortification: Iron fortification - adding iron to foods - is a prophylactic 
approach that is probably the most practical and cost-effective long-term solution to 
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IDA, but its effectiveness depends on the quality of the iron fortificant and the 
frequency of intake of the fortified food. The quality of an iron fortificant depends on 
its bioavailability and compatibility with the food vehicle of choice. Iron salts such as 
NaFeEDTA, ferrous sulphate, and ferrous fumarate have been shown to exhibit 
reasonable bioavailability. These salts have also been shown to retain the taste and 
appearance characteristics of food vehicles by not causing off-flavors or color changes 
when used in appropriate concentrations (United Nations [UN], 2001). As for 
frequency of use, in many developing countries the use of fortified foods depends 
mainly on socioeconomic status. Resource-poor households that are most frequently 
afflicted by IDA lack both market and economic access to fortified products. More 
importantly, in these countries the major constraint on the success of food fortification 
is the need for central processing facilities, as poor populations seldom purchase 
processed foodstuffs, instead growing and consuming their own food (Zimmermann & 
Hurrell, 2007). 
Based on this overview of the conventional approaches to addressing iron 
deficiency, it is clear that a new and complementary strategy that provides more iron 
at an affordable cost and does so principally via the agricultural system is needed to 
further reduce and better address nutritional ID among resource-poor populations 
worldwide. 
 
Biofortification of staple foods 
Because agriculture is the principal source of most micronutrients, it has been 
postulated that micronutrient malnutrition as it exists today is the consequence of 
malfunctioning food systems that fall short of delivering sufficient nutrients to meet 
human requirements. Thus efforts are now being dedicated to addressing these 
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deficiencies via agricultural interventions aimed at improving the micronutrient 
quality of foods (Graham et al., 2007). 
Biofortification of staple foods as lead by HarvestPlus
®
 focuses on increasing 
the pro-vitamin A, iron, and zinc content of crops using plant breeding strategies 
(Nestel et al., 2006). Research has shown that the enrichment traits available for iron 
and zinc within the genomes of staple crops allow for sizeable increases in the 
micronutrient content of these foods without diminishing yields. Moreover, 
micronutrient-dense seeds can increase crop yields even when planted in 
micronutrient-poor soils. And if the enrichment traits appear to be relatively stable 
across various soil types and climatic environments, it is possible for biofortification 
to target resource-poor populations around the globe while complementing and 
enhancing other nutrition interventions (Welch & Graham, 2002). 
The advantage of biofortification lies in its ability to target both the root causes 
of nutritional deficiencies (dysfunctional food systems) and at-risk populations (rural 
poor who grow and consume their own foods). In the case of iron deficiency, iron 
biofortification of
 
staple foods that dominate the diets of resource-poor households can 
help increase dietary iron intake and/or absorption in such households, whose 
members form the bulk of those suffering from nutritional iron deficiency and its 
consequences (Nestel et al., 2006). The success of biofortification as an agricultural 
intervention will depend on the extent to which such iron-biofortified lines can 
maintain or improve the iron status of iron deficient populations. Its effectiveness will 
be influenced by: i) iron concentration of staple food, ii) iron bioavailability, iii) 
amount of staple food consumed, and iv) potential of biofortified food to increase iron 
status. Hence, our goal is to determine explicitly whether nutritionally enhanced crop 
lines significantly improve the amount of dietary iron absorbed from iron-biofortified 
foods. 
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Iron Nutrition 
Iron is an abundant mineral element in the earth‘s crust that is vital to both 
plants and animals. In plants, iron is involved in redox reactions, it facilitates carbon, 
sulfur, and nitrogen assimilation, and it is critical for cholorphyll formation, 
photosynthesis, and respiration (Taiz & Zeiger, 2006). Iron uptake is therefore tightly 
regulated to prevent iron toxicity and, yet provide sufficient iron to enable proper 
function (Theil & Briat, 2004). We cannot over-emphasize the importance of iron in 
the human diet. It is an essential mineral for life, largely because of its fundamental 
role in oxygen transport and energy metabolism. As a result of the role iron plays in 
human health and disease, intestinal iron absorption and its regulation have been the 
focus of intense research for several decades (Yip, 2001).
 
 
Plant iron homeostasis 
Iron homeostasis in plants is a dynamic process resulting from the coordinated 
regulation of a series of processes beginning with iron uptake from the rhizosphere 
and proceeding through iron storage in various vegetative organs. This process 
depends on a plant‘s genotype and nutritional status as well as on other environmental 
conditions such as soil pH and soil inorganic matter concentration (Theil & Briat, 
2004; Grusak, 2001). 
A plant‘s ability to absorb iron from the soil will often be limited by its 
availability at the surface of the root. In response to deficiencies, plant roots solubilize 
and absorb iron using one of two strategies (Hirsch & Sussman, 1999): 
Iron uptake in strategy-I: Strategy-I, which is characterized by an increase in 
the reducing capacity of roots, is evident in dicotyledonous plants such as beans and 
non-graminaceous monocotyledonous plants such as coconut (Hirsch & Sussman, 
1999). The first step in strategy-I is soil acidification. Roots first solubilize Fe
3+
 by 
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acidifying the rhizosphere with protons and small organic acids in particular citric and 
malic acids, which increases ferric iron solubility and availability (Taiz & Zeiger, 
2006). The next step is the reduction of ferric iron to the more soluble ferrous form. 
Root plasma membranes contain iron-chelating reductase enzymes that have the 
capacity to alter the redox state of iron prior to membrane influx (Taiz & Zeiger, 
2006). For example, in Arabidopsis, ID induces the synthesis of FRO2, a ferric-chelate 
reductase that reduces ferric iron to ferrous iron (Robinson et al., 1999). The last step 
in strategy-I is iron uptake, in which Fe
2+
 is absorbed from the rhizosphere into the 
cytoplasm via a transporter. In Arabidopsis, for example, an iron-regulated transporter 
1 (IRT1) transports Fe
2+
 into the cytoplasm. 
Iron uptake in strategy-II: Strategy-II, which is present in grasses, is 
characterized by the secretion of ferric chelating compounds like mugeneic acids 
(MA). These compounds are also known as phytosiderophores (Hirsch & Sussman, 
1999). The first step in strategy-II involves the biosynthesis of MA from 
nicotianamine in the roots. The second step is the secretion of MA into the 
rhizosphere. This is followed by the chelation of Fe
3+
 by MA (Sugiura & Nomoto, 
1984), and the resulting MA–Fe3+ complex is then taken up into the cytoplasm via a 
plasma-membrane transporter (Hirsch & Sussman, 1999; Römheld & Marschner, 
1986). 
Roots can also excrete iron chelators such as malic acid, citric acid, or 
phenolics to form complexes with Fe
3+
, which are then absorbed by the plant. For 
example, in grasses such as corn or barley, roots secrete a siderophore, which forms 
highly stable complexes with Fe
3+
 that are then taken up by the root via the Fe
3+
 - 
siderophore transport system (Taiz & Zeiger, 2006). 
In addition to physiological adaptation, plants can undergo root morphology 
changes so as to increase the root surface area and thus absorb more iron. In 
8 
 
Arabidopsis, for example, iron deficiency induces the formation and elongation of root 
hairs; in red clover (Trifolium pretense L.) it increases lateral root length; and in 
sunflowers it results in swelling at the root tips (Jin et al., 2008; Schmidt, 1999; 
Landsberg 1996). 
A study of iron uptake in plants, focusing in particular on the presence of ID, 
shows complex, highly regulated interactions between plant roots and the rhizosphere 
(Schmidt, 1999), revealing the formidable challenges involved in breeding for 
increased iron in food crops. More information is required to further comprehend iron 
homeostasis in plants. Fortunately, ongoing research on various crops such as 
Arabidopsis, maize and rice continues to reveal the molecular mechanisms governing 
iron homeostasis in plants (Krämer, Talke & Hanikenne, 2007). This new found 
knowledge will be instrumental in guiding plant breeding strategies for iron-
biofortified staple foods. 
 
Human iron homeostasis 
Iron Function: Iron-containing compounds in the body can be classified into 
two groups: functional iron in the form of hemoglobin, myoglobin, and cytochromes; 
and storage iron in the form of ferritin and hemosiderin - a water insoluble degradation 
product of ferritin (Stipanuk 2000; Yip, 2001; Institute of medicine [IOM] 2001). 
About two-thirds of the iron in the body is present in the erythrocytes as 
hemoglobin, a molecule composed of four units each containing one heme group and 
one protein chain. In hemoglobin iron serves as a carrier of oxygen from the lungs to 
the tissues. Myoglobin is an oxygen storage protein located in the cytoplasm of muscle 
cells with a structure similar to that of hemoglobin, but it has only one heme unit and 
one globin chain. In myoglobin, iron controls the rate of oxygen diffusion from 
capillary red blood cells to the cytoplasm and mitochondria of muscle cells. 
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Cytochromes include several iron-containing enzymes that have one heme group and 
one globin protein chain. These enzymes act as electron carriers within the cell. Their 
role in oxidative metabolism is to transfer energy within the cell and, more 
specifically, in the mitochondria. Other key functions of iron-containing enzymes 
include the synthesis of steroid hormones and bile acids; detoxification of foreign 
substances in the liver; and signal controlling in some neurotransmitters, such as the 
dopamine and serotonin systems in the brain (Stipanuk 2000; Yip, 2001; IOM 2001). 
Storage iron comprises 20-30% of total body iron and is especially important 
in young children and women of childbearing age as a reservoir during emergency 
blood loss. Ferritin and hemosiderin are stored mainly in the liver, spleen, and bone 
marrow and are used primarily for the production of hemoglobin as well as for 
meeting other cellular iron needs (Stipanuk 2000; Yip, 2001; IOM 2001). 
Iron Absorption: The capacity of iron to either accept or donate electrons and 
readily interchange between Fe
2+
 and Fe
3+ 
makes it an essential micronutrient for life, 
as it plays a crucial role in a number of processes (Yip, 2001). Nevertheless, this redox 
activity can also result in the production of oxygen-free radicals, which can damage 
various cellular components. Thus iron levels must be tightly controlled so as to 
provide for cellular needs without developing the toxicity caused by an excess of iron. 
Since the body lacks a discrete mechanism for the active excretion of iron, its levels 
are regulated at the point of absorption, primarily in the proximal small intestine 
(Frazer & Anderson, 2005). 
There are two pathways for the absorption of iron in humans. One supports the 
uptake of heme iron derived from hemoglobin and myoglobin in meats, while the 
other mediates the absorption of non-heme iron (Yip, 2001). This discussion will 
focus mainly on the absorption of non-heme iron. 
10 
 
The process of nonheme iron transport across the intestinal epithelium can be 
divided into three steps: (a) uptake from the intestinal lumen, (b) mucosal intracellular 
transport, and (c) transfer to systemic circulation (see Figure 1.2). 
 
  
DMT-1
Dcytb
Fe3+
Fe2+
Fe2+
Fe2+ Ferritin
Fe2+
Ferroportin
Intestinal Lumen
Blood
Transferrin
Fe3+ Fe3+
Hephaestin
Enterocyte
Apical
Membrane
Basolateral 
membrane
HepcidinFe adequacy
Inflammation
Transferrin 
saturation
Fe deficiency 
Figure 1.2: Schematic diagram of nonheme iron uptake at the enterocyte. 
 
(a) Iron uptake from the intestinal lumen: Most absorption of dietary iron is 
carried out by mature villus enterocytes of the duodenum and proximal jejunum. The 
uptake of iron from the lumen of the intestine across the apical membrane and into the 
enterocyte is mediated by the brush border iron transporter divalent metal transporter 1 
(DMT-1), which transports iron in ferrous form. Because much of the iron that enters 
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the lumen of the duodenum is in ferric form it is reduced, likely enzymatically, by a 
brush border ferric reductase known as duodenal cytochrome b (Dcytb; see Frazer & 
Anderson, 2005). 
(b) Mucosal intracellular iron transport: The intracellular movement of iron 
from the brush border membrane to the basolateral membrane is not completely 
understood. Some suggest that intracellular iron may be bound to chaperone molecules 
to maintain its solubility, but to date none have been identified—although DMT-1 has 
been proposed as one of the potential carrier proteins (Ma et al., 2002, Yeh et al., 
2008). Iron not transferred to the body is incorporated into the iron storage molecule 
ferritin and is lost in the feces when the cell is ultimately sloughed at the villus tip 
(Frazer & Anderson, 2005). 
(c) Iron transfer to systemic circulation: The transfer of iron across the 
basolateral membrane and into systemic circulation is believed to be mediated by the 
iron transport proteins ferroportin and hephaestin. Ferroportin (Fp) is the only known 
cellular iron exporter in vertebrates that is not only necessary for the release of iron 
from the enterocyte, but is also known to be involved in the export and recycling of 
iron from other cell types, including macrophages (Domenico et al., 2008). Hephaestin 
(Hp), a ceruloplasmin homologue, is thought to interact with ferroportin to facilitate 
the movement of iron across the membrane. Its role as a ferroxidase is to re-oxidize 
ferrous iron to form ferric iron, thus facilitating Fe
3+
 binding to transferrin (Tf), a 
circulating iron carrier in the blood (Vulpe et al., 1999). 
Iron Transportation in the body: Once in circulation (bound to transferrin in 
the plasma), iron is transported to specific peripheral body tissue sites, where the 
transferrin-iron complex is sequestered by transferrin receptor proteins and, after 
undergoing receptor-mediated endocytosis, which internalizes the entire complex into 
clathrin-coated vesicles, the iron is eventually released from transferrin into the cell 
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cytoplasm and the transferrin is recycled back to the blood stream (Goswami, Rolfs & 
Hediger, 2002). In the absence of bleeding, iron is fairly well conserved by the body 
and only about 1mg iron/day may be lost through excretion (Bothwell et al., 1979).
 
Regulation of iron absorption in the body: Early models of iron absorption 
regulation were based on the programming of crypt cells. As previously mentioned, 
mature absorptive enterocyte cells constitute the major site of iron absorption. These 
villus enterocytes differentiate from crypt cells during migration from the crypts to the 
apex of the villus. The early models of the regulation of iron absorption suggested that 
in normal, healthy individuals the sensing of bodily iron status by duodenal crypt cells 
might effect a change in the iron absorptive activity of daughter enterocytes. These 
models propose that the crypt cells of the distal duodenum sense bodily iron status 
through the uptake of Tf-bound iron. The human hemochromatosis protein (HFE) 
associates with transferrin receptor (TfR) proteins on the basolateral surface, resulting 
in the internalization of Tf-bound iron into the crypt cells. When Tf saturation is low, 
less iron is transferred via DMT1 into the cytosol, resulting in a relatively iron-
deficient state in the crypt cells. Consequently, binding of iron-regulatory proteins 
(IRPs) to the 3' untranslated region (UTR) of iron-regulatory elements (IREs) 
increases, resulting in increased mRNA stability for iron transport genes—DMT1, 
Dcytb, Fp and Hp—expressed on differentiation of these cells to villus absorptive 
enterocytes. On the other hand, when Tf saturation is high, IRPs bind to the 5' UTR of 
IREs, blocking mRNA translation for these iron transport genes and thus reducing 
their abundance in the resulting mature villus absorptive enterocytes (Fleming & 
Britton, 2006; Pietrangelo, 2002; Philpott 2002). The crypt cell hypothesis is 
supported by results from a mouse study conducted to test the hypothesis that the HFE 
gene is involved in the regulation of iron homeostasis (Zhou et al., 1998). In this 
study, researchers studied the effects of a targeted disruption of the murine homologue 
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of the HFE gene on iron homeostasis. Even on a standard diet, the HFE-deficient mice 
showed profound increases in transferrin saturation and hepatic iron compared with 
what occurs in the wild type, suggesting that, in crypt cell programming, HFE is the 
main protein involved in the regulation of iron transfer into the blood. 
With the discovery of hepcidin, however, a new model for the regulation of 
iron absorption emerged. Hepcidin, a hepatic bactericidal protein, has been shown to 
affect the function, distribution, and concentration of ferroportin and is thought to 
regulate iron efflux from enterocytes and macrophages by binding to Fp and inducing 
its internalization and degradation (Nemeth et al., 2004). Thus reduced levels of 
hepcidin may lead to
 
tissue iron overload, while overproduction of hepcidin could 
result in hypoferremia and the anemia of inflammation. Hepcidin production is 
regulated by high iron levels, inflammatory stimuli, and demand for erythropoiesis 
(Beutler, 2004; Hentze, Muckenthaler, & Andrews, 2004). On this contemporary 
model of iron absorption, hepcidin controls plasma iron by modulating iron absorption 
in the gut, the release of recycled hemoglobin iron by macrophages, and the movement 
of stored iron from hepatocytes. Evidence from a rat study conducted by Frazer et al. 
(2002) supports the role of hepcidin over crypt cell programming as the process of 
regulation of iron absorption in the epithelial cell. In their study adult rats were 
switched from an iron-replete to an iron-deficient diet and the expression of Dcytb, 
DMT1, Fp, and Hp in their duodena, as well as hepcidin in their livers, was studied 
over a 14-day period. The researchers also analyzed the effect of the ID diet on iron 
absorption and iron status. The switch from an iron-replete to an ID diet resulted in a 
rapid change in gene expression in both the duodenum and liver. Increases in Dcytb, 
DMT1, and Fp expression in the duodenum were observed, but not of Hp. On the 
other hand, hepcidin expression in the liver decreased almost simultaneously. Crypt 
cell migration is thought to take about three to five days, so the rapid nature of these 
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changes (within one day) is thought to support the proposed role of hepcidin in 
signaling the bodily iron requirements to the epithelial cells. Frazer et al. also noted 
that the changes in gene expression occurred before changes in both hematologic and 
storage iron were evident, but were correlated precisely with a change in transferrin 
saturation, which suggests that Tf saturation may be a regulatory factor for hepcidin 
regulation and iron absorption. 
 
Iron Bioavailability 
Iron absorption in humans is influenced by many factors, including dietary iron 
content, iron bioavailability, and bodily storage iron status (Yip, 2001). In human 
nutrition terms, bioavailability is commonly defined as the proportion of a nutrient in a 
food or meal that is absorbable and utilizable by the person eating the food or meal. In 
the case of iron, it is characterized as the percentage of dietary iron that is absorbed 
and utilized by an individual (Benito & Miller, 1998). Thus the total concentration of a 
nutrient in a food or diet does not necessarily reflect the consumer-available nutrient 
supply within a food system, and this is especially true with regard to micronutrients 
such as iron. Therefore in the case of iron biofortified foods it is essential to determine 
if the amount of bioavailable iron in the enriched lines can improve the iron status of 
the targeted populations (King, 2002; Welch & Graham 2002). 
Dietary iron occurs in two forms: heme iron and non-heme iron. In the human 
diet the primary sources of heme iron are hemoglobin and myoglobin from meat, 
poultry, and fish. Non-heme iron is obtained from cereals, pulses, legumes, fruits, and 
vegetables. It occurs in plants in various forms in differing proportions with varied 
chemical properties according to food source (Hallberg, 1981). Bioavailability of 
heme iron averages about 25 percent, compared with 2-8 percent from non-heme iron 
in plant foods. This difference between non-heme and heme iron in terms of 
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bioavailability may be explained by the fact that heme iron is thought to be absorbed 
intact by receptor mediated endocytosis and its absorption is only slightly influenced 
by other constituents of the diet. As for non-heme iron, its chemical form significantly 
affects its absorption, independently of other dietary compounds that could further 
alter dietary iron absorption (West & Oates, 2008; Hallberg, 1981). 
Iron bioavailability in plant foods is influenced by dynamic factors and the 
interactions that make iron bioavailability complex. Some factors increase the 
absorption and utilization of iron and these are referred to as enhancers or promoters 
of iron bioavailability. On the other hand, other factors inhibit iron absorption and 
utilization and these are known as inhibitors of iron bioavailability or antinutrients. 
Some of these factors are dietary while others are non-dietary. 
Non-dietary factors that influence iron density/content in crops include genetic 
selection, certain agronomical practices, soil pH, and fertility, while characteristics 
such as age, sex, ethnicity, nutritional status, or the disease status of an individual can 
influence iron absorption and utilization in the body. In addition, food processing or 
preparation methods may increase iron bioavailability; milling, fermentation, and 
cooking are but a few such processes known to improve iron bioavailability in plant 
foods (Ruel & Levin, 2002; Graham, Welch & Bouis, 2001; Benito & Miller, 1998; 
Hallberg, 1981). 
In the case of dietary factors that influence iron bioavailability, it is difficult to 
cite a unifying concept to account for the many factors that may inhibit or promote the 
efficiency with which dietary iron is incorporated into the body. There are multiple 
interactions that occur between iron and other macronutrients, micronutrients, or plant 
substances in a single-meal or whole diet that may enhance or inhibit iron absorption 
by the gut. Studies show that phytate and polyphenols are the major compounds that 
inhibit iron bioavailability, especially from plant-based diets (Hu et al., 2006; 
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Davidsson, 2003; Hallberg, Brune & Rossander, 1989; Morck, Lynch & Cook, 1983; 
Hallberg & Rossander, 1982b; Disler & others, 1975). On the other hand, ascorbic 
acid, organic acids such as tartaric acid, malic acid, succinic acid, and fumaric acid, 
and meats are said to enhance iron bioavailability (Hurrell et al., 2006; Salovaara, 
Sandberg & Andlid, 2002; Yip, 2001; Hallberg, Brune & Rossander-Hulthén, 1987).  
 
Measurement of iron bioavailability 
As already mentioned, iron bioavailability is defined as the proportion of iron 
in the meal that is digested, absorbed, and ultimately utilized for normal body 
functions (Fairweather-Tait et al., 2007). This definition recognizes and encompasses 
the concept that iron bioavailability involves the entire process of iron transfer from 
food into the body—iron digestibility, uptake, efflux, retention, utilization, and 
storage. Historical and current methods have been developed over time to assess these 
different aspects of iron bioavailability in foods (Table 1.1). 
In vivo iron models (human and animal studies) and in vitro iron models (for 
example, the Caco-2 cell assay) are used to assess iron bioavailability. Human and 
animal studies may be categorized as isotopic or non-isotopic, depending on whether 
iron isotope tracers are used. Iron isotopes- 
54
Fe,
 57
Fe,
 58
Fe, are commonly used in 
stable isotope studies while 
55
Fe, 
59
Fe are generally used in radioisotope studies to 
determine iron bioavailability of foods in in vivo iron models (Wienk, Marx & 
Beynen, 1999). 
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Table 1.1: Historical & current methods used to assess aspects of iron bioavailability. 
Assay/Technique Assessment 
Solubility 
Dialyzability 
Assess iron release from food 
Duodenal loops Assess  iron absorbed into the blood 
Caco-2 cell assay 
Assess iron availability from foods 
Ferritin formation
 
by Caco-2 cells is used as an indicator of 
iron uptake 
Isotope techniques Assess quantity of absorbed iron retained in the body 
Hemoglobin 
incorporation / 
repletion 
Assess iron utilization for normal body functions 
 
In vitro methods have also been used extensively to study food-based iron 
bioavailability. Until recently, solubility and dialyzability were measured to estimate 
iron bioavailability by determining the amount of iron dissolved from food by dilute 
acids or the extractability of ionizable iron from food by chelating agents. More recent 
in vitro methods are based on simulated digestion of food or test meals with pepsin, 
hydrochloric acid, and sometimes other digestive enzymes, followed by determination 
of the dialyzable or soluble iron released (Wienk, Marx & Beynen, 1999; Fairweather-
Tait et al., 2007). A good example of this method is the in vitro digestion/Caco-2 cell 
model that has been adapted to assess iron availability from foods (Figure 1.3). The 
model employs the Caco-2 cell line in conjunction
 
with in vitro digestion, whereby 
foods undergo simulated peptic digestion followed by pancreatic-bile
 
digestion in the 
presence of Caco-2 cell monolayers. These cells exhibit remarkable morphological 
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and biochemical similarity to the small intestinal cells, the primary site for iron 
absorption in the human gastrointestinal tract. For example, the Caco-2 cells form 
monolayers when cultured and contain brush border microvilli, enzymes, and transport 
proteins. They also maintain distinct apical and basolateral membranes (Pinto et al., 
1983). The Caco-2 cell model is a very useful screening tool that has shown enormous 
potential in addressing iron bioavailability issues (Glahn et al., 1998; Yun et al., 
2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Schematic diagram of in vitro digestion/Caco-2 cell iron model. 
 
Arithmetic models and algorithms have also been used to estimate food-based 
iron bioavailability. These models are based on existing data from iron bioavailability 
studies and are used to predict iron bioavailability from the diet (Wienk, Marx & 
Beynen, 1999; Au & Reddy, 2000). An analysis of six iron absorption prediction 
equations conducted by Beard et al. (2007) revealed, however, that these equations 
Food Preparation (1g DW)
Pepsin Digestion
pH 2, 1 h, 37 C (50 mL tube)
Pancreatin-Bile Digestion
pH 6.8 – 7.0, 2 h, 37 C (1.5mL)
Soluble iron
Insert ring
Culture well
Dialysis membrane
15K MWCO
Caco-2 cells
Harvest cells for ferritin and cell protein 
determination 24 h post start of Pancreatin-
Bile digestion
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exhibit a lack of agreement with each other and with the change in iron status as 
estimated by serum ferritin. Thus their validity in estimating iron bioavailability from 
foods remains questionable. A recent study by Rickard et al. (2009) has developed an 
algorithm used to assess intestinal iron availability for use in dietary surveys. The 
proposed algorithm is to be used to predict available iron in the gut and not iron 
absorption from the meal or diet. And although this algorithm by Rickard et al. seems 
to be an improvement from previous algorithms, further research is needed to evaluate 
its application beyond the population-level.  
 
Study design, goals and objectives 
The first step in breeding for improved nutrient density in crops is to identify 
the nutrient and the staple crop of interest. After this has been achieved, the goal of 
plant breeding in biofortification is to use available breeding methods to exploit the 
natural genetic diversity in the crop of interest so as to improve the nutritional quality 
of that crop. Previous iron biofortification efforts using conventional breeding have 
proved successful in rice (Haas et al., 2005) and iron biofortified beans have been 
tested in piglets with positive effects (Tako et al., 2009). The focus of our study was 
iron biofortification of maize using conventional breeding methods with the aid of a 
quantitative trait loci (QTL) model. 
Experimental population: In genetic research programs, recombinant inbred 
lines (RIL) or near isogenic lines (NIL) are commonly used as experimental
 
populations. RIL are produced by continually selfing or sib-mating the progeny of 
individual members of an F2 population until homozygosity is achieved (see Figure 
1.4). NIL can be developed by backcrossing an RIL to the original parent (see Figure 
1.4). There are some advantages to using NIL in research. Because the backcross 
derived lines are highly related to each other except for a small number of key 
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differences, the differences due to chance are relatively small or infrequent such that 
any detected differences are likely significant and related to the selected trait 
(Keurentjes et al., 2007). 
 
F1
RIL#1 RIL#2 RIL#3 RIL#4 RIL#N….
Parent A Parent B
F2 F2 F2 F2 F2
X
X
Cross 2 varieties
F1 is heterozygous for all 
genes
Self/sib
mate until
new 
varieties
are
fixed for
all genes
Parent A Parent B
XX
or
NIL #1.1 NIL #1.2 NIL #21.1 NIL #21.2
RIL as parent
 
Figure 1.4: Schematic diagram of the production of recombinant inbred lines (RIL) 
and near isogenic lines (NIL). 
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RIL and NIL from the Intermated B73 x Mo17 recombinant inbred (IBM RI) 
population formed the experimental population in our study. IBM RI population was 
made from B73 (a temperate, stiff stalk) inbred and Mo17 (a temperate, non-stiff 
stalk) inbred, and is the best characterized mapping population in maize. IBM is a 
powerful resource for the analysis of quantitative traits and genetic mapping in maize 
(Lee et al. 2002; Sharopova et al. 2002; Falque et al. 2005) 
Analysis of quantitative traits in iron biofortified maize: Many important 
agricultural traits, such as crop yield, are referred to as quantitative traits. Such traits 
exhibit a continuous distribution that can be measured and given a quantitative value. 
Quantitative traits are often affected by multiple genes and environmental factors. The 
quantitative traits of interest in our study were iron concentration and the amount of 
bioavailable iron in the IBM RI maize population. 
Analysis of quantitative trait loci in iron biofortified maize: The alleles that 
control for quantitative traits occur in pairs and are located in loci on homologous 
chromosomes. The loci are therefore referred to as quantitative trait loci (QTL). The 
form of the gene that can exist at a single locus is determined by its DNA sequence 
and is referred to as an allele. Alleles can be either dominant or recessive. When 
different forms of an allele occur at a locus, it is heterozygous. When the alleles are 
the same it is homozygous, and can be either dominant or recessive (see Figure 1.5).  
QTL analysis is a statistical method in plant research that allows breeders to 
link two types of information - phenotypic data (such as grain iron concentration or 
grain iron bioavailability) and genotypic data (usually molecular markers) - in an 
attempt to explain the genetic basis of variation in quantitative traits. In our study, 
QTL in the IBM RI maize population were analyzed to determine chromosomal 
regions that contain QTL that may influence grain iron concentration and the amount 
of bioavailable iron in our maize population. 
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Figure 1.5: Schematic diagram of homologous chromosome 
 
QTL model for iron biofortified maize: The main goal of characterizing 
quantitative trait loci in a segregating population is to determine how many genes are 
involved in the genetic control of the quantitative trait of interest and to estimate their 
location within the genome. The QTL model summarizes the genetic factors that 
contribute to the trait of interest, explaining where each of them are in the genome, 
and their relative contribution to the total phenotypic variance explained. The model is 
based on the fact that phenotypic differences for the trait of interest can be traced back 
to genetic markers located at specific positions on the chromosome (Koornneef, 
Alonso-Blanco & Peeters, 1997). The model can often be deduced from the statistical 
analysis of several segregating populations, and it helps researchers understand 
inheritance, variation in quantitative traits of interest, and predict future outcomes 
(Koornneef, Alonso-Blanco & Peeters, 1997; Gai & Wang, 1998). In our study a QTL 
model was employed to locate loci in the IBM RI maize population that influence iron 
concentration and iron bioavailability in the maize grain.  
Gene loci
A b c
Recessive
allele
Genotype:
A b C
Dominant
allele
AA bb Cc
Homozygous
for the
dominant allele
Homozygous
for the
recessive allele
Heterozygous
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Analysis of iron content in iron biofortified maize: Mineral analysis was 
conducted using inductively coupled plasma-emission spectroscopy (ICAP; ICAP 
model 61E Trace Analyzer; Thermo Jarrell Ash Corporation, Waltham MA) 
Analysis of iron bioavailability in iron biofortified maize: Analysis of the 
amount of bioavailable iron was done in vitro using the Caco-2 cell iron model and in 
vivo using a poultry model. 
By targeting principally poor populations at risk of suffering micronutrient 
deficiencies, biofortification has the potential, as an agricultural intervention, to 
complement other approaches aimed at reducing or preventing micronutrient 
malnutrition. However, for biofortification to be successful the biofortified crops must 
prove to be beneficial to the populations that adopt and consume them. In the case of 
iron biofortified maize, (1) breeding efforts must improve iron density or 
bioavailability in maize, (2) the trait should be relatively stable across locations, soils 
and climatic regions it is adapted for, and (3) the nutritionally improved crop lines 
must improve the iron status of at-risk populations (Welch & Graham, 2002, see figure 
1.6). 
The overall goal of this research was to make a significant contribution toward 
breeding efforts for iron in maize. The specific objectives of the study were to (a) 
determine the quantitative trait loci that influence iron content and iron bioavailability 
in the maize grain, (b) examine environmental factors that may influence iron nutrition 
in maize, and (c) assess iron bioavailability from biofortified maize. To achieve these 
objectives, this research work was divided into three main studies that addressed 
specific research questions as listed:  
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Figure 1.6: Tenets for biofortification success 
 
Study 1: Enhancing iron bioavailability in maize using a Caco-2 cell/ QTL model. 
 Is iron concentration in maize a genetically tractable trait? 
 Is iron bioavailability in maize a genetically tractable trait? 
 
Study 2: Evaluating Genotype x Environment interaction in biofortified maize. 
 Does growing biofortified maize in different locations affect iron 
concentration and/or iron bioavailability in the maize lines? 
 
Study 3: Assessment of iron bioavailability from iron biofortified maize. 
 Are significant differences in iron bioavailability as measured by the 
Caco-2 cell in vitro model reflected in an in vivo model? 
Breeding for high 
nutrient content or 
quality must be 
feasible 
The biofortification 
genotype traits must 
be relatively stable 
across environments 
Farmer adoption 
and consumer 
acceptance are vital 
Micronutrients in 
improved
 
lines must  
be bioavailable 
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CHAPTER 2 
ENHANCING IRON BIOAVAILABILITY OF MAIZE USING A CACO-2 
CELL / QUANTITATIVE TRAIT LOCI MODEL 
 
Abstract 
The aims of this study were to determine if there is a significant difference in 
grain iron concentration and grain iron bioavailability in intermated B73 x Mo17 
recombinant inbred maize populations grown in Aurora, New York in 2007 and 2008. 
Grain iron concentration was determined using emission spectroscopy and grain iron 
bioavailability was assessed using the Caco-2 cell bioassay. Using the Caco-2 cell/ 
QTL (quantitative trait loci) model, we identified two hybrid maize lines from our 
2007 maize population with identical grain iron concentration (20 ppm), but one line 
contained double the amount of bioavailable iron (P = 0.0064). In the 2008 maize 
population, we found two inbred maize lines with similar grain iron concentration (25 
ppm) but one line had 7 times more bioavailable iron than the other one had (P < 
.0001). These data can be explained either by the enhanced levels of a promoter or a 
suppression of an inhibitor through breeding, or a combination of both. Additional 
research is required to profile and identify the compounds. We conclude that 
conventional breeding using the QTL approach can significantly improve iron 
bioavailability in maize grain. The next step is to assess genotype-by-environment 
interaction, a process in which improved lines should be grown at multiple locations. 
In vivo bioavailability trials should be conducted to determine the efficacy
 
of 
consuming the high bioavailable iron maize. 
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Introduction 
Iron deficiency is an important public health problem that is estimated to affect 
over one-third of the world‘s population (Zimmermann & Hurrell, 2007). Improving 
the nutritional quality of staple food crops such as maize, by developing varieties with 
high bioavailable iron content, represents a sustainable and cost-effective approach to 
alleviating iron malnutrition (Welch & Graham, 2004). Biofortification is an 
agricultural intervention that seeks to improve human health by improving 
micronutrient levels in staple foods (Nestle et al., 2006). For biofortification to 
succeed, the first step is to ensure that the enhancement of nutritional quality is 
primarily under genetic control. 
Rapid developments in maize genetics and genomics coupled with the need to 
integrate nutrition goals into agriculture has resulted in extensive interest and research 
in breeding for enhanced iron quality in maize varieties. One approach has sought to 
improve iron bioavailability in maize varieties by reducing iron inhibitors in maize. 
For example, to reduce phytic acid in maize, Raboy (2002) and others isolated low-
phytic-acid mutations
 
of maize and used these to show proof of principal that 
conventional breeding can be used to breed first-generation low-phytate maize 
varieties. Another approach is the use of transgenic breeding to improve iron nutrition 
in maize. For instance, to increase grain bioavailable iron in maize, Drakakaki et al. 
(2005) generated transgenic maize plants with endosperm-specific co-expression of 
Aspergillus phytase and soybean ferritin. In spite of their potential for success 
however, efforts to reduce phytate in crops and transgenic plants are mired in either 
scientific or political debate (Shamsuddin, 2008; Wainwright & Mercer, 2009). There 
is therefore a need to find a conventional breeding strategy that can improve the iron 
nutrition of maize and is ‗perceived as safe‘ to both consumers and the environment. 
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Using conventional breeding, previous studies, such as Hoekenga et al. 
(manuscript submitted for publication), have sought to employ an integrated genetic 
and physiological analysis of iron nutrition in maize grain to determine the 
quantitative trait loci (QTL) that influence grain iron concentration and grain iron 
bioavailability in intermated B73 x Mo17 (IBM) recombinant inbred (RI) maize 
populations. From their studies, forty-two QTL for grain iron concentration 
(explaining 21 – 81% of the variance detected in a given year/location) were detected 
from samples collected over three years in Aurora, New York and one year in Clayton, 
North Carolina. Six out of the forty-two QTL were repeatedly detected, explaining 7 - 
27% of the observed variance in grain iron concentration.  
For grain iron bioavailability, loci associated with increased amounts of 
bioavailable iron were identified on 6 chromosomes and explained 54% of the 
observed variance in samples from a single year/location. Three of the largest iron 
bioavailability QTL were successfully isolated in near-isogenic lines (NILs). 
However, none of the identified QTL for grain iron content and grain iron 
bioavailability were co-located. In addition, grain iron bioavailability was not 
correlated with either grain iron concentration or phytate levels. 
In regard to grain iron concentration, numerous genes may be involved in 
controlling iron absorption in the root-soil interface of the maize grain. These genes 
are located in QTL, so locating these QTL can facilitate the breeding process by 
providing important information about the location of iron nutrition genes in the maize 
genome, the number of genes that affect this nutrition trait, and the distribution of the 
genes in the maize genome. This information is essential to breeders because it can 
help them to distinguish between linkage and pleiotrophy and major genes and minor 
genes, as well as to clarify the mode of gene action. The results of the study by 
Hoekenga et al. lay the foundation for the follow-up research presented in this chapter. 
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The objectives of this study were: (i) to determine if there was a significant difference 
in grain iron concentration in IBM RI maize populations grown in Aurora, New York 
in 2007 and 2008, and (ii) to determine if there was a significant difference in grain 
bioavailable iron in these IBM RI maize populations. 
 
Materials and Methods 
Chemicals, enzymes, and hormones: Unless otherwise stated, all chemicals, 
enzymes, and hormones were purchased from Sigma Chemicals Co. To prepare 
reagents for cell culture, 18 MΩ water was used. Glassware and utensils used in the 
experiments were soaked in 1.2 M HCl for at least 4 hours and rinsed in deionized 
water prior to use. 
Plant materials and field site details: The maize varieties tested are derived 
from Intermated B73 x Mo17 (IBM) recombinant inbred (RI) maize populations. The 
IBM RI population was selected for this study based on ready availability and the 
existence of advanced backcross families for rapid development of near-isogenic lines 
(NIL). One maize population was grown in Aurora, NY in 2007. It consisted of 
seventeen Mo17 background lines, thirty three B73 background lines and two hybrid 
lines. A second maize population, some of it derived from the 2007 maize population, 
was grown in Aurora NY, in 2008. It consisted of twenty-five Mo17 background lines 
and 43 B73 background lines The plots used for this study had a Lima Silt Loam soil, 
with average yield for maize of 120 bushels acre
-1
 and water extractable soil pH of 7.7. 
Maize sample preparation: Maize kernels (20g) were sorted to remove any 
debris or damaged seeds and then placed in a 50 mL centrifuge tube and covered with 
25 mL of 18 MΩ water. Samples were then autoclaved at 121ºC and at a pressure of 
115 kPa for 40 min, allowed to cool at room temperature, and then frozen overnight at 
–20 C. Samples were then freeze-dried at 100 millTorr and a temperature of –50 C 
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for 7 days, ground to a fine powder with a coffee mill (90 sec), and stored in 50 mL 
centrifuge tubes at 25 C. Tamale maize—used as a control in the Caco-2 cell 
bioassay—was prepared in an identical manner. 
Mineral analysis for maize samples: A 0.3g dry ground maize sample was 
weighed into borosilicate glass test tubes and chemically digested using 4 mL of 
concentrated nitric acid at 120 C until the residue was light brown to yellow in color. 
Exactly 1.0 ml of a 50/50 mixture of concentrated nitric acid and perchloric acid was 
then added, and the temperature was increased to 180 C. After 2 hours, the 
temperature was further increased to 240 C until the digested samples were dry. After 
cooling, 0.25 mL of concentrated hydrochloric acid was added to dissolve the ash. 
One hour later, the sample was diluted with 10 mL of 5% nitric acid. The ashed 
sample was then mixed and transferred into 15 mL auto sampler tubes and analyzed 
on an axially viewed inductively coupled plasma (ICP) trace analyzer emission 
spectrometer (model ICAP 61E trace analyzer, Thermo Electron, Waltham, MA; see 
Rutzke, 2002). 
Caco-2 cell screening: The in vitro digestion Caco-2 cell iron model was used 
as a screening tool to estimate the amount of bioavailable iron in the maize samples. 
Cell Culture: Caco-2 cells were obtained from the American Type Culture 
Collection (Rockville, MD) at passage 17 and used in experiments at passages 25–33. 
Cells were seeded at a density of 50,000 cells/cm
2
 in collagen-treated six-well plates 
(Costar Corp., Cambridge, MA). The cells were grown in Dulbecco‘s Modified Eagle 
Medium (GIBCO, Grand Island, NY) with 10% v/v fetal calf serum (GIBCO), 25 
mmol/L N-(2-Hydroxyethyl) piperazine-N‘-2-ethane sulfonic acid (HEPES), and 1% 
antibiotic antimycotic solution (GIBCO). The cells were maintained at 37 C in an 
incubator with a 5% CO2/95% air atmosphere at constant humidity, and the medium 
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was changed every 2 days. The cells were used in the iron uptake experiments at 13 
days post seeding. 
In Vitro Digestion: The preparation of the digestion solutions—pepsin, 
pancreatin, and bile extract—and the in vitro digestion was performed as previously 
published (Glahn et al., 1998). Briefly, 1.0 g of dry sample was used for each sample 
digestion. Ascorbic acid (AA) was added to enhance iron bioavailability using a 20:1 
AA: Fe molar ratio. Then 10 ml of a pH 2 140 mM NaCl, 5 mM KCl buffer was added 
to the samples, and the mixture was pH re-adjusted to pH 2. Then 0.5 mL of pepsin 
solution was added to each of the samples prior to incubation. After a 1-hour 
incubation period, the sample pH was adjusted to pH 5.5 to 6.0 with 1.0 M NaHCO3, 
and after the addition of 2.5 mL of pancreatin-bile solution, the sample pH was further 
adjusted to pH 6.9-7.0 with 1.0 M NaHCO3. Sample volumes were then adjusted (by 
weight) to tube weight plus 15 g using the 140 mM NaCl, 5 mM KCl pH 6.7. Finally, 
1.5 mL of the sample was transferred to appropriate inserts on the Caco-2 cell plates. 
Harvesting: The harvesting of the Caco-2 cell monolayers was performed as 
previously published (Glahn et al., 1998). The cells were harvested after a 24-hour 
incubation period. First, growth media were carefully aspirated off the cells. The cells 
were then rinsed twice with 2 mL of 130mM NaCl, 5 mM PIPES, pH 6.7 buffer. To 
harvest the cells, 2 mL of 18.2 M  water was added to the cells, and the cells were 
placed in a sonicator (Lab-line Instruments, Melrose Park, IL) at 4 C for 15 minutes. 
The cells were then scraped off the plates, suspended in the 2 mL of 18.2 M  water, 
and transferred to pre-labeled 5 ml tubes in anticipation of protein and ferritin assays. 
Cell Protein Analysis: Caco-2 cell protein was measured on samples that had 
been solubilized in 0.5 mol/L NaOH, using a semimicro adaptation of the Bio-Rad DC 
protein assay kit (Bio-Rad Laboratories, Hercules, CA). A 25 µL sample of the 
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sonicated Caco-2 cell monolayer, harvested in 2 mL of water, was used for each 
protein measurement expressed in mg. 
Ferritin Analysis: A one-stage, two-site immunoradiometric assay was used to 
measure Caco-2 cell ferritin content (FER-Iron II Ferritin Assay, RAMCO 
Laboratories, Houston, TX). A 10 µL sample of the sonicated Caco-2 cell monolayer, 
harvested in 2 mL of water, was used for each ferritin measurement expressed per unit 
of cell protein (ng ferritin/mg cell protein). 
Statistical Analyses: Statistical analyses of the data were performed using the 
GraphPad Prism v4 (GraphPad Software, San Diego, CA) and JMP v7.0 (SAS 
Institute Inc., Cary, NC) software packages. In some cases, the data were log-
transformed prior to analysis. Means were considered to be significantly different for 
P values ≤ 0.05. 
 
Results 
The objectives of this study were to determine if there was a significant 
difference in grain iron concentration and grain bioavailable iron in the IBM RI maize 
populations grown in Aurora, New York in 2007 and 2008. The maize populations 
were analyzed for grain iron concentration using emission spectroscopy and grain 
bioavailable iron using the Caco-2 cell bioassay. 
 
(1a) Grain iron concentration – 2007 harvest: Table 2.1 shows a summary 
of grain iron concentration data for maize samples from the 2007 harvest. The maize 
populations consisted of two hybrid lines and 50 inbred lines. Seventeen of the inbreds 
were Mo17 lines, and 33 were B73 lines. The statistical model for grain iron 
concentration showed a significant difference in grain iron concentration in this IBM 
RI maize population (P = 0.0133). The grain iron concentration in the hybrid lines was 
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significantly different from that in the inbred lines. Grain iron concentration in the 
B73 maize lines was not significantly different from grain iron concentration in the 
Mo17 maize lines. 
There was a significant difference in grain iron concentration across the 
samples in the three groups. Grain iron concentration was significantly different 
within the Mo17 lines (n = 17, P <.0001) and B73 lines (n = 33, P <.0001), 
respectively. However, a t-test revealed no significant difference in grain iron 
concentration between the two hybrid lines (P = 0.4407). 
 
 (1b) Grain iron concentration – 2008 harvest: Table 2.2 shows a summary 
of grain iron concentration data for maize samples from the 2008 harvest. The maize 
population consisted of 68 inbred lines. Twenty-five of the inbreds were Mo17 lines, 
and 43 were B73 lines. The statistical model for grain iron concentration showed a 
significant difference in grain iron concentration in this IBM RI maize population (P 
<.0001). Grain iron concentration in the B73 maize lines was significantly different 
from grain iron concentration in the Mo17 maize lines. 
There was also a significant difference in grain iron concentration between the 
samples within the two maize lines. Grain iron concentration was significantly 
different within the Mo17 lines (P <.0001) and within the B73 lines (P <.0001), 
respectively. 
 4
2
 
 
 
 
 
 
 
Table 2.1: Grain iron concentration of maize lines grown in Aurora, NY in 2007. 
 
Grain iron concentration (2007 harvest) 
Mean (ppm) Median (ppm) Range (ppm) 
Hybrid lines (n = 2) 20.49 20.49 20.30 - 20.67 
Mo17 background lines (n = 17) 22.37 23.04 15.29 - 27.47 
B73 background lines (n= 33) 22.36 22.10 17.17 - 29.38 
All IBM RI population 22.29 22.61 15.29 - 29.38 
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As previously mentioned, some maize samples harvested in 2008 were derived 
from one or two of the maize lines from the 2007 harvest. A comparison of grain iron 
concentration between the parental lines (2007 harvest) and daughter lines (2008 
harvest) revealed no significant differences in grain iron concentration between the 
2008 maize samples and either parent (parent 1, range = 17.17 - 27.47 ppm, P = 
0.1635; parent 2, range = 23.12 – 24.81 ppm, P = 0.1726). This suggests that grain 
iron content is a genetically tractable trait in the IBM RI maize population. 
 
(2a) Grain bioavailable iron – 2007 harvest: Figures 2.1 – 2.3 show a 
summary of grain bioavailable iron (as a percentage of the control) for the Mo17 lines, 
the B73 lines, and the two hybrid lines from the 2007 harvest. The statistical model for 
grain iron bioavailability showed a significant difference in grain bioavailable iron in 
the IBM RI maize population (P <.0001). Grain bioavailable iron in the B73 lines was 
significantly different from that in the hybrid and Mo17 lines. Grain bioavailable iron 
in the hybrid maize lines was not significantly different from that in the Mo17 maize 
lines. 
There was a significant difference in grain bioavailable iron across samples 
within the three groups (P <.0001). Grain bioavailable iron was significantly different 
within the Mo17 lines (P <.0001) and B73 lines (P <.0001), respectively. A t-test also 
revealed a significant difference in grain bioavailable iron between the two hybrid 
lines (P = 0.0064). 
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                               Table 2.2: Grain iron concentration of maize lines grown in Aurora, NY in 2008. 
 
Grain iron concentration (2008 harvest) 
Mean 
(ppm) 
Median (ppm) Range (ppm) 
Mo17 background lines (n= 17) 23.57 23.71 17.58 - 27.79 
B73 background lines (n = 33) 20.32 19.96 15.52 - 26.86 
All IBM RI population 21.48 21.79 15.52 - 27.79 
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Figure 2.1: Caco-2 cell ferritin formation. The amount of bioavailable iron 
in the Mo17 lines was assessed using the Caco-2 cell model. Ferritin formation in 
the cells is an index of iron bioavailability. One gram (dry weight) of each sample 
was analyzed in the model. Bar values (mean ± SEM, n = 6). 
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Figure 2.2: Caco-2 cell ferritin formation. The amount of bioavailable iron in the B73 lines was assessed 
using the Caco-2 cell model. Ferritin formation in the cells is an index of iron bioavailability. One gram (dry 
weight) of each sample was analyzed in the model. Bar values (mean ± SEM, n = 6). 
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Figure 2.3: Caco-2 cell ferritin formation. The amount of bioavailable iron in 
the hybrid lines was assessed using the Caco-2 cell model. Ferritin formation in the 
cells is an index of iron bioavailability. One gram (dry weight) of each sample was 
analyzed in the model. Statistical analysis was performed by one-way ANOVA and 
student‘s t test. Column values (mean ± SEM, n = 6) with no letters in common are 
significantly different (P < 0.05). 
 
(2b) Grain bioavailable iron – 2008 harvest: Figures 2.4 – 2.5 show a 
summary of grain bioavailable iron (as a percentage of the control) for the Mo17 and 
B73 lines from the 2008 harvest. The statistical model for grain iron bioavailability 
showed a significant difference in grain bioavailable iron in this IBM RI maize 
population. A student‘s t-test revealed a significant difference in grain bioavailable 
iron between the two groups—the Mo17 and B73 lines (P <.0001). There was a 
significant difference in grain bioavailable iron across samples within the two groups. 
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Grain bioavailable iron was significantly different within the Mo17 lines (P <.0001) 
and the B73 lines (P <.0001), respectively. 
As mentioned earlier, maize samples harvested in 2008 were derived from 
maize lines from the 2007 harvest. A comparison of grain bioavailable iron between 
the parental lines (2007 harvest) and daughter lines (2008 harvest) revealed no 
significant differences in grain iron concentration between the 2008 maize samples 
and the parent 1 samples (P = 0.5688).  
It is worth noting that the Caco-2 cell screening data from the 2007-2008 
breeding cycle using the QTL approach isolated two hybrid maize lines from the 2007 
maize population with identical grain iron concentration (20 ppm), but one line 
contained double the amount of bioavailable iron (P = 0.0064). In the 2008 maize 
population, we similarly found two inbred maize lines—sample 96 and sample 103—
with similar grain iron concentration but one line had significantly more bioavailable 
iron (P < .0001). Grain iron nutrition details for the two inbred lines are shown in 
Table 2.3. These results further enforce our hypothesis that the breeding method 
employed is either enhancing levels of an iron bioavailability promoter, suppressing 
an iron bioavailability inhibitor, or a combination of both. Additional research is 
required to profile and identify the compounds.  
 
Table 2.3: Grain iron concentration and bioavailable iron from inbreeds 96 and 103. 
 
                     Inbred line (2008 harvest) 
                           96 103 
Mean grain iron concentration (ppm) 25.14 24.75 
Caco-2 cell ferritin formation (ng/mg; mean ± SEM) 4.0 ± 0.2 29.0 ± 1.2 
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Figure 2.4: Caco-2 cell ferritin formation. The amount of bioavailable iron in the Mo17 lines (2008 harvest) 
was assessed using the Caco-2 cell model. Ferritin formation in the cells is an index of iron bioavailability. One 
gram (dry weight) of each sample was analyzed in the model. Bar values (mean ± SEM, n = 6). 
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Figure 2.5: Caco-2 cell ferritin formation. The amount of bioavailable iron in the B73 lines (2008 harvest) 
was assessed using the Caco-2 cell model. Ferritin formation in the cells is an index of iron bioavailability. One 
gram (dry weight) of each sample was analyzed in the model. Bar values (mean ± SEM, n = 6). 
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Discussion 
Studies on iron bioavailability have shown that simply increasing grain iron 
content may not automatically result in improved iron bioavailability in the grain. It is 
therefore a challenge when limited resources force breeders to choose between 
breeding for iron content and breeding for iron bioavailability. Our breeding work 
focused on breeding for iron bioavailability. The Caco-2 cell bioassay was used in this 
study as an in vitro screening tool for bioavailable iron. The in vitro iron model allows 
for rapid and cost-effective analysis of numerous genotypes and has produced iron 
bioavailability results that have been consistent with genetic data obtained through the 
QTL model. 
The current breeding program that supports this study is based on the QTL 
model and has been ongoing for the past seven years. In 2002 - 2003, new genetic 
resources were created for a maize breeding program by Hoekenga (Owen Hoekenga, 
personal communication). The objective was to create maize lines from the IBM RI 
population that could be used for genetic analysis of multiple genetic traits in maize. 
The preliminary data indicated breeding for improved iron nutrition in maize was a 
complex task. Quantitative trait loci and marker-assisted analyses were carried out 
using both single-marker analysis (SMA) and composite interval mapping (CIM). The 
SMA that is less conservative identified ten QTL, while the more conservative CIM 
identified three QTL that influenced iron bioavailability in maize. The data also 
suggested that the iron biofortification breeding program should focus on grain iron 
bioavailability relative to grain iron concentration (Hoekenga, manuscript submitted 
for publication). 
In 2002, the first cross between the B73 and IBM mapping lines was 
backcrossed to the original maternal parent (B73). The resulting maize material was 
self-pollinated (selfed) in 2005, producing about 600 sister maize lines that exhibited 
52 
either improved or diminished iron bioavailability potential. Due to limited resources 
only 37 of these lines that had the most promise for iron biofortification were 
evaluated using the Caco-2 cell assay. Analysis of grain iron concentration and grain 
iron bioavailability in these lines confirmed the 3 QTL predicted in the initial study 
and showed that iron traits were heritable and thus genetically tractable (Hoekenga et 
al., manuscript submitted for publication).  
The information derived from the Caco-2 cell bioassay (grain iron 
bioavailability data) together with the information obtained from the QTL model (loci 
identity) was then used to generate new maize varieties. Improved maize lines 
exhibited superior QTL while the diminished lines exhibited inferior QTL (the three 
iron bioavailability QTL isolated using CIM). In 2007, new lines were cross-pollinated 
(improved vs. improved and diminished vs. diminished) to produce two hybrids with 
improved and diminished iron bioavailability potential, respectively. As seen in the 
results section, the hybrid pair had the same grain iron concentration but one line 
contained double the amount of bioavailable iron (P < 0.001). Based on these results, 
two new hybrid lines were created to produce a modest amount of grain that would be 
used to test iron bioavailability in a poultry model. The results of this study are 
presented in chapter 4 of this dissertation. 
Also highlighted in the results section are two inbred maize lines—sample 96 
and sample 103—from the 2008 maize population. These maize lines are similar to the 
previously highlighted results of the 2007 hybrid maize lines. They showed identical 
grain iron concentration (25 ppm) but one line had significantly more bioavailable 
iron. These data suggest the following: (1) grain iron concentration in this maize 
population is not significantly associated with grain iron bioavailability and (2) the 
iron biofortification approach used affects iron bioavailability in maize by either 
enhancing or suppressing secondary metabolites that affect iron bioavailability. It is 
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therefore plausible that the QTL approach is breeding for secondary compounds that 
enhance iron bioavailability in maize. It could be that the breeding method suppresses 
iron inhibitory compounds in the maize. Or that both scenarios play out at the same 
time, enhancing iron promoters while suppressing iron inhibitors. It is also possible 
that the QTL approach is breeding for secondary compounds that inhibit iron 
bioavailability in maize. Metabolic profiling of the hybrids and inbred lines is required 
to answer this question conclusively.  
This study has yielded additional evidence that QTL information can be 
combined with iron bioavailability data from the Caco-2 cell bioassay to 
experimentally create or select candidate maize lines with either superior or inferior 
iron nutrition qualities. Multi-year breeding studies have shown that the Caco-2 
cell/QTL method gives consistent results and can be used to breed for improved iron 
nutrition in maize provided that the resulting lines give the expected results in vivo. 
Further research is required to search for additional QTL that may influence iron 
bioavailability in maize and to determine the mode of gene action in the superior allele 
maize lines. The current research work has focused mainly on temperate maize 
varieties adopted for iron nutrition research. However, the target populations for iron 
biofortification grow and consume mainly tropical maize varieties. Concomitant iron 
biofortification efforts should therefore also focus especially on collaborating with 
maize breeders in Sub-Saharan Africa to transfer superior alleles into tropical and sub-
tropical elite maize lines, assess bioavailability and genotype-by-environment 
interaction, and finally conduct in vivo trials to determine the efficacy
 
of consuming 
such high bioavailable iron maize. 
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Conclusion 
The IBM RI population selected for this study was based on easy availability 
and the existence of advanced backcross families for rapid development of near-
isogenic lines. The alleles present in IBM RI may not represent the best alleles 
available for improved iron nutrition quality in maize grain. For optimal effect, the 
breeding program should therefore expand to identify any additional alleles that could 
be included in the breeding process. And although iron biofortification of maize via 
conventional breeding is a complex task, both grain iron content and iron 
bioavailability are genetically tractable traits. The Caco-2 cell/ QTL approach, coupled 
with in vivo testing can significantly improve iron bioavailability in maize grain. To 
make further progress, additional work in molecular genetics as well as metabolite 
testing is required. Collaboration with maize breeders in Sub-Saharan countries should 
also be pursued. 
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CHAPTER 3 
ASSESSMENT OF GENOTYPE X ENVIRONMENT INTERACTION IN  
IRON BIOFORTIFIED MAIZE 
 
Abstract 
This study was undertaken with two objectives: to evaluate the effects of 
interaction between genotype and environment (G×E) and to determine the association 
between soil iron status on grain iron concentration and the amount of bioavailable 
iron in six maize genotypes grown in five diverse locations. Grain iron concentration 
was determined using emission spectroscopy and grain iron bioavailability was 
assessed using the Caco-2 cell bioassay. The six maize genotypes tested were derived 
from the Intermated B73 x Mo17 recombinant inbred maize population and grown in 
selected locations in New York, Missouri, North Carolina, Iowa, and Pennsylvania. 
Grain iron concentration ranged from 17.34 ppm – 36.32 ppm. Grain iron 
bioavailability ranged from 36.39% below to 75.26% above that of the reference 
control sample. The results indicated a significant G×E interaction for both grain iron 
concentration and grain iron bioavailability (P <.0001). Correlation data indicated a 
highly significant (P<.0001) negative correlation between total soil iron and grain iron 
bioavailability but no significant association between either soil extractable iron and 
grain iron concentration or grain iron bioavailability. We conclude that (G×E) 
interaction has an effect on iron trait expression. 
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Introduction 
Maize (Zea mays L.) is one of the most important staple food crops in the 
world. In Africa and Latin America, maize kernels are processed into a variety of 
traditional food products such as pastes, gruels, porridges, tortillas and polenta. The 
rural poor in these geographical regions rely mostly on monotonous cereal-based diets 
to meet their nutrient requirements. Improving the nutritional quality of cereals such as 
maize can therefore have a significant impact on their nutritional status. 
Biofortification is an agricultural intervention that seeks to improve human 
health by improving micronutrient levels in staple foods (Nestle et al., 2006). Using 
conventional plant breeding, the biofortification strategy can significantly contribute 
to alleviating micronutrient deficiencies such as iron deficiency anemia (IDA). To do 
so the first step is to ensure that the enhancement of nutritional quality is under genetic 
control. Next, possible interaction between genotypes and the environment (G×E) 
must be investigated. To succeed, the potential enhancement of iron nutritional quality 
in maize must be relatively stable across diverse environments (Welch & Graham, 
2004). Recent studies have reported wide variations in grain iron concentration in 
maize (Pfeiffer & McClafferty, 2007). One study that evaluated 1,814 maize 
germplasms reported grain iron concentration ranging between 9.6 and 63.2 mg/kg. 
These variations in concentration were attributed to both genetic and environment 
effects (Bänziger & Long, 2000). 
The expression of a phenotype of an individual plant is determined by both the 
genotype and the environment. However, these two effects are not always additive 
because of interaction between the genotype and the environment (G×E). 
Equation 3.1: Phenotype = Genotype + Environment + (G×E) interaction 
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G×E interaction is a result of inconsistent genotype performance across environments 
caused by variations due to location and/or climatic zone. A significant G×E 
interaction results from changes in the magnitude of differences between genotypes in 
diverse environments or from changes in the relative ranking of the genotypes 
(Fernandez, 1991). To make any substantial progress in biofortification efforts, it is 
vital that breeders evaluate and understand factors that contribute to G×E interactions 
in their breeding programs, as this will reflect trait heritability,
 
genetic variation, and 
potential genetic gains. 
 An increasing body of evidence suggests that the expression
 
of iron in cereals 
such as maize can be subject to G×E interaction (Hoekenga et al., unpublished data). 
The goal of our study was to assess the G×E interaction in maize derived from the 
Intermated B73×Mo17 (IBM) maize population grown in diverse locations. The 
selected lines had been grown in Aurora, New York in 2007 and chosen for further 
study including the G×E evaluation study based on their iron bioavailability potential 
determined using the Caco-2 cell in vitro iron model. In 2008, the same lines were 
again grown in the New York location, and by our collaborators in selected locations 
in Missouri, North Carolina, Iowa, and Pennsylvania. The objectives of the study 
were: (i) to analyze grain iron concentration and amount of bioavailable iron from 
grain samples grown in our selected locations; (ii) to determine the association 
between soil iron status and both grain iron concentration and amount of bioavailable 
iron from grain samples grown in our selected locations; and (iii) to evaluate grain 
iron trait stability by analyzing the effects of genotype, environment and G×E 
interaction on grain iron concentration and amount of bioavailable iron. 
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Materials and Methods 
Chemicals, enzymes, and hormones: Unless otherwise stated, all chemicals, 
enzymes, and hormones were purchased from Sigma Chemicals Co. To prepare 
reagents for cell culture, 18 MΩ water was used. Glassware and utensils used in the 
experiments were soaked in 1.2 M HCl for at least 4 hours and rinsed in deionized 
water prior to use. 
Plant materials and field site details: The maize varieties tested are derived 
from the Intermated B73 x Mo17 (IBM) recombinant inbred (RI) maize population. 
These lines were selected for this study on the basis of their iron bioavailability 
potential, as indicated by the Caco-2 cell bioassay. Table 3.1 summarizes the genotype 
description of the maize varieties. Four derivatives from the IBM RI population were 
created to demonstrate significant differences in grain iron nutritional quality in maize. 
Near-isogenic lines were derived from IBM RIL #264 by back-crossing to the B73 
parent (high iron nutritional quality B73 or ―HB‖ and low iron nutritional quality B73 
or ―LB‖) and from IBM RIL #039 by back-crossing to the Mo17 parent (―HM‖ and 
―LM‖). The four near-isogenic varieties (HB, LB, HM, and LM) and their respective 
hybrids (see Table 3.1) were initially grown in 2007 in Aurora, New York and 
analyzed for iron concentration and amount of bioavailable iron. Based on their iron 
bioavailability potential, the maize lines were grown at research farms owned by 
Cornell University (Aurora, NY), Iowa State University (Boone, IA), North Carolina 
State University (Clayton, NC), The Pennsylvania State University (Fairpoint, PA), 
and The University of Missouri (Columbia, MO) in the Summer of 2008. 
Table 3.1: Genotype description of the maize varieties. 
Maize sample number
1
 Description
2
 Iron bioavailability potential
3
 Genotype number 
1/ 1a/1b
*
 IBM264 BC2 B73 S3 
(LB) 
Low (LB) 1 
2/2a/2b IBM039 BC2 Mo17 S3 
(LM) 
Low (LM) 2 
3/3a/3b LB×LM hybrid Low 3 
4/4a/4b IBM264 BC2 B73 S3 
(HB) 
High (HB) 4 
5/5a/5b 1BM039 BC2 Mo17 S3 
(HM) 
High (HM) 5 
6/6a/6b HB×HM hybrid High 6 
1. Maize varieties grown in 2008 in five selected locations; *some locations had replicate plots, hence the reference to a/b. Six 
genotypes were grown in each location. 
2. BC = Backcross; S = Self. 
3. Iron bioavailability potential is based on the Caco-2 cell analysis of maize grown in Aurora, NY in 2007. Low iron nutritional 
quality B73 and Mo17 lines are abbreviated LB and LM, respectively. High iron nutritional quality B73 and Mo17 lines are 
abbreviated HB and HM, respectively. 
 
 
 
6
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Table 3.2 gives a brief description of the selected locations where the maize 
trials were planted. The plots used in Aurora, New York had a Lima Silt Loam soil, 
with average yield for maize of 120 bushels acre
-1
 and water extractable soil pH of 6.7. 
The plots used in Boone, Iowa had a Webster Clay Loam soil, with average yield for 
maize of 210 bushels acre
-1
 and water extractable soil pH of 6.1. The plots used in 
Clayton, North Carolina had a Norfolk Loamy Sand soil, with average yield for maize 
of 106 bushels acre
-1
 and water extractable soil pH of 6.4. The plots used in Fairpoint, 
Pennsylvania had a Hagerstown Silt Loam soil, with average yield for maize of 135 
bushels acre
-1
 and water extractable soil pH of 5.9. The plots used in Columbia, 
Missouri had a Leonard Silt Loam soil, with average yield for maize of 176 bushels 
acre
-1
 and water extractable soil pH of 6.3. These descriptions of soil conditions were 
obtained from the Web Soils Survey of the National Resource Conservation Service 
(http://websoilsurvey.nrcs.usda.gov).
Table 3.2: Brief description of selected locations where trials were planted. 
 
Location
1
 
 
 
Ecozones Altitude 
(meters) 
Annual Min/Max 
Temp 
( C) 
Mean annual 
rainfall 
(cm) 
Ames, IA Temperate grasslands /savanna and shrubland 304.80 3.4 - 16.7 92.20 
Columbia, MO Temperate broadleaf /mixed forest 243.84 6.4 - 19.5 102.31 
Clayton, NC Temperate broadleaf /mixed forest 106.68 8.3 - 22.2 116.08 
Aurora, NY Temperate broadleaf /mixed forest 125.88 3.9 - 14.2 93.93 
State College, PA Temperate broadleaf /mixed forest 384.05 4.2 - 15 100.99 
 
 
 
 
 
6
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1. IA = Iowa, MO = Missouri, NC = North Carolina, NY = New York, PA = Pennsylvania. 
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Maize sample preparation: Maize kernels (20g) were sorted to remove any 
debris or damaged seeds and then placed in a 50 mL centrifuge tube and covered with 
25 mL of 18 MΩ water. Samples were then autoclaved at 121° C and at a pressure of 
115 kPa for 40 min, allowed to cool at room temperature, and then frozen overnight at 
–20 C. Samples were then freeze-dried at 100 millTorr and a temperature of –50 C 
for 7 days, ground to a fine powder with a coffee mill (90 sec), and stored in 50 mL 
centrifuge tubes at 25 C. A tamale maize sample, used as a control in the Caco-2 cell 
bioassay, was prepared in an identical manner. 
Mineral analysis for maize samples: A 0.3g dry ground maize sample was 
weighed into borosilicate glass test tubes and chemically digested using 4 mL of 
concentrated nitric acid at 120 C until the residue was light brown to yellow in color. 
Exactly 1.0 ml of a 50/50 mixture of concentrated nitric acid and perchloric acid was 
then added, and the temperature was increased to 180 C. After 2 hours, the 
temperature was further increased to 240 C until the digested samples were dry. After 
cooling, 0.25 mL of concentrated hydrochloric acid was added to dissolve the ash. 
One hour later, the sample was diluted with 10 mL of 5% nitric acid. The ashed 
sample was then mixed and transferred into 15 mL auto sampler tubes and analyzed 
on an axially viewed inductively coupled plasma (ICP) trace analyzer emission 
spectrometer (model ICAP 61E trace analyzer, Thermo Electron, Waltham, MA; see 
Rutzke, 2002). 
Caco-2 cell screening: The in vitro Caco-2 cell iron model was used as a 
screening tool to estimate the amount of bioavailable iron in the maize samples. 
Cell Culture: Caco-2 cells were obtained from the American Type Culture 
Collection (Rockville, MD) at passage 17 and used in experiments at passages 25–33. 
Cells were seeded at a density of 50,000 cells/cm
2
 in collagen-treated six-well plates 
(Costar Corp., Cambridge, MA). The cells were grown in Dulbecco‘s Modified Eagle 
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Medium (GIBCO, Grand Island, NY) with 10% v/v fetal calf serum (GIBCO), 25 
mmol/L N-(2-Hydroxyethyl) piperazine-N‘-2-ethane sulfonic acid (HEPES), and 1% 
antibiotic antimycotic solution (GIBCO). The cells were maintained at 37 C in an 
incubator with a 5% CO2/95% air atmosphere at constant humidity, and the medium 
was changed every 2 days. The cells were used in the iron uptake experiments at 13 
days post seeding. 
In Vitro Digestion: The preparation of the digestion solutions—pepsin, 
pancreatin, and bile extract—and the in vitro digestion was performed as previously 
published (Glahn et al., 1998). Briefly, a 1.0 g dry sample was used for each sample 
digestion. Ascorbic acid (AA) was added to enhance iron bioavailability using a 20:1 
AA: Fe molar ratio. Then 10 ml of pH 2 140 mM NaCl, 5 mM KCl buffer was added 
to the samples, and the mixture was pH re-adjusted to pH 2. Following this step, 0.5 
mL of pepsin solution was added to each of the samples prior to incubation. After a 1-
hour incubation period, the sample pH was adjusted to pH 5.5-6.0 with 1.0 M 
NaHCO3, and after the addition of 2.5 mL of pancreatin-bile solution, the sample pH 
was further adjusted to pH 6.9-7.0 with 1.0 M NaHCO3. Sample volumes were then 
adjusted (by weight) to tube weight plus 15 g using the 140 mM NaCl, 5 mM KCl pH 
6.7. Finally, 1.5 mL of the samples was transferred to appropriate inserts on the Caco-
2 cell plates. 
Harvesting: The harvesting of the Caco-2 cell monolayers was performed as 
previously published (Glahn et al., 1998). The cells were harvested after a 24-hour 
incubation period. First, growth media were carefully aspirated off the cells. The cells 
were then rinsed twice with 2 mL of 130mM NaCl, 5 mM PIPES, pH 6.7 buffer. To 
harvest the cells, 2 mL of 18.2 M  water was added to the cells, and the cells were 
placed in a sonicator (Lab-line Instruments, Melrose Park, IL) at 4 C for 15 minutes. 
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The cells were then scraped off the plates, suspended in the 2 mL of 18.2 M  water, 
and transferred to pre-labeled 5 ml tubes in anticipation of protein and ferritin assays. 
Cell Protein Analysis: Caco-2 cell protein was measured on samples that had 
been solubilized in 0.5 mol/L NaOH, using a semimicro adaptation of the Bio-Rad DC 
protein assay kit (Bio-Rad Laboratories, Hercules, CA). A 25 L sample of the 
sonicated Caco-2 cell monolayer, harvested in 2 mL of water, was used for each 
protein measurement expressed in mg. 
Ferritin Analysis: A one-stage, two-site immunoradiometric assay was used to 
measure Caco-2 cell ferritin content (FER-Iron II Ferritin Assay, RAMCO 
Laboratories, Houston, TX). A 10 L sample of the sonicated Caco-2 cell monolayer, 
harvested in 2 mL of water, was used for each ferritin measurement expressed per unit 
of cell protein (ng ferritin/mg cell protein). 
Soil Analysis: Soil samples from the five growing locations were analyzed for 
organic matter and pH. The analyses were conducted by the Cornell Nutrient Analysis 
Laboratory (Ithaca, NY). In their tests, lab staff followed methods provided in the Soil 
Survey Laboratory Methods Manual developed by the National Soil Survey Center 
(National Resources Conservation Service, United States Department of Agriculture). 
Statistical Analyses: Statistical analyses of the data were performed using the 
GraphPad Prism v4 (GraphPad Software, San Diego, CA) and JMP v7.0 (SAS 
Institute Inc., Cary, NC) software packages. In some cases, the data were log-
transformed prior to analysis. Means were considered to be significantly different for 
P values 0.05. 
 
Results 
The goal of this study was to determine if grain iron concentration and grain 
iron bioavailability in the six maize genotypes were expressed consistently across all 
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five diverse locations. This is an important assessment because the success of iron 
biofortified maize in addressing iron malnutrition, especially in diverse regions such 
as Sub-Saharan Africa, will depend to a large extent on the stability of these iron traits.  
 
(a) Grain iron concentration: The grain iron concentration of the six maize 
genotypes grown in diverse environments was analyzed using emission spectroscopy. 
Table 3.3 shows the grain iron concentration for each genotype by location. The grain 
iron concentration ranged from 17.34 ppm (Genotype 1b, Iowa) – 36.32 ppm 
(Genotype 4, New York). The mean grain iron concentration was 26.27 ppm.
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Table 3.3: Grain iron concentration of maize varieties grown in five diverse locations. 
Maize sample number
1
 
Grain iron concentration by location
2
 (ppm) 
IA MO NC NY PA 
1/ 1a 17.6 ± 0.4 23.4 ± 4.0 22.4 ± 1.2 19.1 ± 0.1 19.7 ± 0.6 
1b
*
 17.3 ± 0.7 25.3 ± 0.1 25.8 ± 0.4 - - 
2/2a 25.2 ± 0.4 21.2 ± 0.2 24.0 ± 0.8 20.8 ± 0.3 21.1 ± 0.3 
2b 21.3 ± 0.2 20.5 ± 0.2 23.6 ± 5.3 - - 
3/3a 21.3 ± 0.8 22.8 ± 0.7 28.6 ± 0.7 19.9 ± 0.2 19.3 ± 0.1 
3b 19.0 ± 0.5 30.4 ± 0.3 19.1 ± 0.4 19.6 ± 0.5 - 
4/4a 24.6 ± 0.8 20.8 ± 0.7 19.0 ± 0.4 36.3 ± 0.6 20.8 ± 0.1 
4b 25.5 ± 0.2 27.2 ± 6.0 30.1 ± 2.3 - - 
5/5a 24.6 ± 0.1 30.1 ± 2.9 24.7 ± 0.6 27.5 ± 1.1 25.4 ± 0.5 
5b 21.7 ± 0.6 21.6 ± 0.8 20.7 ± 0.5 - - 
6/6a 23.6 ± 0.2 23.5 ± 1.7 21.4 ± 0.4 25.6 ± 1.6 21.5 ±0.1 
6b 22.9 ± 0.5 22.2 ± 1.0 23.7 ± 1.0 30.4 ± 0.4 - 
1. Maize varieties grown in 2008 in five selected locations; *some locations had replicate plots, hence the reference to a/b. 
Six varieties (genotypes) were grown in each location. 
2. Mean ± SD for; IA = Iowa, MO = Missouri, NC = North Carolina, NY = New York, PA = Pennsylvania. 
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A statistical analysis model was used to assess the effects of environment, 
genotype, and the G×E interaction for grain iron concentration. As seen in Table 3.4, 
there was a strong significant interaction term (G×E), and a main effect of genotype. 
 
Table 3.4: Fixed-effects tests for grain iron concentration (JMP v7) 
Source of variation DF F Ratio Prob > F 
Environment 4 3.9162 0.1266 
Genotype 5 12.2342 <.0001 
Genotype*Environment 20 6.1573 <.0001 
 
Further analysis of the G×E interaction was performed using contrast testing 
across environments (Table 3.5). The data revealed significant differences in grain 
iron concentration for genotypes 1, 3, 4, and 6 across the five locations—those in 
Iowa, Missouri, North Carolina, New York, and Pennsylvania. The grain iron 
concentration for genotypes 2 and 5 was not significantly different across the five 
locations. 
 
Table 3.5: Comparison of grain iron concentration across environments (JMP v7) 
Source of variation: Environment DF F Ratio Prob > F 
Genotype 1 4 8.2328 <.0001 
Genotype 2 4 1.3043 0.2875 
Genotype 3 4 5.6272 0.0012 
Genotype 4 4 11.3467 <.0001 
Genotype 5 4 1.5496 0.2095 
Genotype 6 4 4.0832 0.0097 
 
Assessment of the G×E interaction based on genotype (Table 3.6) indicated 
significant differences in grain iron concentration between the six genotypes in the 
Iowa, Missouri, and New York locations. The difference in grain iron concentration 
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between genotypes in the Pennsylvania location was significant after a bonferroni 
correction for multiple comparisons. In the North Carolina location, there was no 
significant difference in grain iron concentration across the six genotypes. 
 
Table 3.6: Comparison of grain iron concentration between genotypes (JMP v7) 
Source of variation: Genotype DF F Ratio Prob > F 
IOWA 5 7.5779 <.0001 
MISSOURI 5 4.1447 0.0010 
NORTH CAROLINA 5 1.1416 0.3425 
NEW YORK 5 19.1962 <.0001 
PENNSYLVANIA 5 2.3561 0.0445 
 
(b) Grain Iron bioavailability: Because the six maize genotypes were chosen 
for the G×E evaluation study based on their iron bioavailability potential we analyzed 
the iron bioavailability data in two ways; 1) Group data analysis for all the six growing 
locations, and 2) Individual data analysis for the individual growing locations. 
(1) Group data analysis: Amount of bioavailable iron was assessed using the 
Caco-2 bioassay (Figure 3.1). The mean amount of bioavailable iron ranged from 
36.39% below (Genotype 1; Pennsylvania) to 75.26% above (Genotype 5b; Missouri) 
that of the reference control sample. The statistical analysis model assessed the effects 
of environment, genotype, and the interaction of the two (G×E) for grain iron 
bioavailability. As seen in Table 3.7, there was a strong significant interaction term 
(G×E; P <.0001) and a significant main effect of both genotype (P <.0001) and 
environment (P = 0.0025). 
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Figure 3.1: Caco-2 cell ferritin formation. The amount of bioavailable iron in G×E maize lines was assessed with the 
use of the Caco-2 cell model. Ferritin formation in the cells is an index of iron bioavailability. One gram (dry weight) of 
each sample was analyzed in the model. Bar values (mean ± SEM, n = 6). G×E = Genotype by Environment. 
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Table 3.7: Fixed-effects tests for grain iron bioavailability (JMP v7) 
Source of variation DF F Ratio Prob > F 
Environment 4 72.6915 0.0025 
Genotype 5 7.5441 <.0001 
Genotype*Environment 20 5.0377 <.0001 
 
Further analysis of the G×E interaction based on environment (Table 3.8) 
revealed significant differences in grain iron bioavailability for all six genotypes 
across all five locations. 
 
Table 3.8: Comparison of grain iron bioavailability across environments (JMP v7) 
Source of variation: Environment DF F Ratio Prob > F 
Genotype 1 4 39.5151 <.0001 
Genotype 2 4 26.4247 <.0001 
Genotype 3 4 12.4183 <.0001 
Genotype 4 4 20.8360 <.0001 
Genotype 5 4 18.6711 <.0001 
Genotype 6 4 8.1758 <.0001 
 
Additionally, the assessment of the G×E interaction for grain iron 
bioavailability based on genotype (Table 3.9) showed a strong significant difference in 
grain iron bioavailability among the six genotypes in the Iowa, Missouri, New York, 
and Pennsylvania locations. There was no significant difference in grain iron 
bioavailability among genotypes grown in the North Carolina location. 
 
Table 3.9: Comparison of grain iron bioavailability among genotypes (JMP v7) 
Source of variation: Genotype DF F Ratio Prob > F 
IOWA 5 9.090 <.0001 
MISSOURI 5 5.7933 <.0001 
NORTH CAROLINA 5 1.1087 0.3561 
NEW YORK 5 6.8874 <.0001 
PENNSYLVANIA 5 4.9439 0.0002 
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(2) Individual data analysis: As earlier mentioned, six maize genotypes were 
grown in five diverse environments to evaluate the G×E interaction. The objective of 
the individual data analysis was to further analyze the six maize genotypes in more 
detail, so as to evaluate location-specific changes in the magnitude of differences 
between genotypes or changes in the relative ranking of the genotypes. It was 
expected, based on genotypic data, that samples 1, 1a, 1b, 2, 2a, 2b, 3, 3a, and 3b 
would exhibit low bioavailability potential, while samples 4, 4a, 4b, 5, 5a, 5b, 6, 6a, 
and 6b were expected to exhibit high bioavailability potential, with significant 
differences between the two groups.  The data analysis also compared the B73, Mo17, 
and hybrid pair lines- LB vs. LM, HB vs. HM, and low vs. high respectively to 
determine which of the two lines showed the expected responses in the individual 
locations.  
 
(i) Grain iron bioavailability – Iowa: There was a strong significant difference in 
grain iron bioavailability among the six genotypes in the Iowa location (P < .0001). 
Table 3.10 shows least square means differences in grain iron bioavailability 
determined using Tukey HSD. Iron bioavailability of low bioavailability potential 
inbreds and hybrids - 1a, 2a, 2b, 3a and 3b - was to expectation, with no significant 
differences between these samples. Only sample 1b was significantly different from 
the hybrids. Iron bioavailability of high bioavailability potential inbreds and hybrids – 
4a, 4b, 5a, 5b, 6a and 6b - was to expectation, with no significant differences between 
these samples. Comparing inbred and hybrid pair lines - samples 1 vs. 4, 2 vs. 5 and 3 
vs. 6 - that were expected to have different iron bioavailability potentials, the data 
showed significant differences in iron bioavailability in some of the inbreds but not the 
hybrids. 
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Table 3.10: Least square means differences in grain iron bioavailability (Iowa) 
Sample 
Iron bioavailability 
potential 
    Least Sq Mean 
IA 5a High Mo17 A    61.214394 
IA 6b High hybrid A B   58.113211 
IA 6a High hybrid A B   57.775122 
IA 5b High Mo17 A B C  51.418968 
IA 3b Low hybrid A B C  48.682535 
IA 3a Low hybrid A B C  47.804331 
IA 4a High B73 A B C  46.648502 
IA 4b High B73 A B C  45.234433 
IA 2a Low Mo17  B C D 43.494930 
IA 2b Low Mo17   C D 39.508113 
IA 1a Low B73   C D 36.003422 
IA 1b Low B73    D 27.242046 
Levels not connected by same letter are significantly different. 
 
(ii) Grain iron bioavailability – Missouri: There was a strong significant 
difference in grain iron bioavailability among the six genotypes in the Missouri 
location (P < .0001). Table 3.11 shows least square means differences in grain iron 
bioavailability determined using Tukey HSD. Iron bioavailability of low 
bioavailability potential inbreds and hybrids - 1a, 1b, 2b, 3a, and 3b was similar but 
significantly differently from sample 2a. Iron bioavailability of high bioavailability 
potential inbreds and hybrids – 4a, 4b, 5a, 5b, 6a and 6b - was erratic, with significant 
differences between sample 5b and samples 4a, 4b, 6a and 6b; and sample 5a and 
samples 4b and 6b. Comparing inbred and hybrid pair lines - samples 1 vs. 4, 2 vs. 5 
and 3 vs. 6 - that were expected to have different iron bioavailability potentials, the 
data showed no significant differences in iron bioavailability of the inbreds or hybrids. 
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Table 3.11: Least square means differences in grain iron bioavailability (Missouri) 
Level 
Iron bioavailability 
potential 
     Least Sq Mean 
MO 5b High Mo17 A     61.826652 
MO 2a Low Mo17 A B    55.229579 
MO 5a High Mo17 A B C   53.613752 
MO 2b Low Mo17 A B C D  48.195062 
MO 6a High hybrid  B C D E 43.961985 
MO 4a High B73  B C D E 42.068521 
MO 3b Low hybrid  B C D E 41.608298 
MO 3a Low hybrid   C D E 39.640411 
MO 1b Low B73    D E 39.019928 
MO 1a Low B73    D E 38.229385 
MO 4b High B73    D E 35.876057 
MO 6b High hybrid     E 31.276452 
Levels not connected by same letter are significantly different. 
 
(iii) Grain iron bioavailability – North Carolina: There was a strong significant 
difference in grain iron bioavailability among the six genotypes in the North Carolina 
location (P < .0001). Table 3.12 shows least square means differences in grain iron 
bioavailability determined using Tukey HSD. Iron bioavailability was significantly 
different in some of the low bioavailability potential inbreds and hybrids, and some of 
the high bioavailability potential inbreds and hybrids. Comparing inbred and hybrid 
pair lines - samples 1 vs. 4, 2 vs. 5 and 3 vs. 6 - that were expected to have different 
iron bioavailability potentials, the data showed no significant differences in iron 
bioavailability between the pair groups but showed block differences between samples 
3a and 3b, and samples 5a and 5b. 
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Table 3.12: Least square means differences in grain iron bioavailability 
(North Carolina) 
Level 
Iron bioavailability 
potential 
  Least Sq Mean 
NC 1a Low B73 A  60.436106 
NC 3a Low hybrid A  59.734394 
NC 5b High Mo17 A  59.261932 
NC 4a High B73 A  56.705525 
NC 1b Low B73 A  56.222450 
NC 6a High hybrid A  55.375447 
NC 2a Low Mo17 A B 53.093886 
NC 4b High B73 A B 52.981395 
NC 6b High hybrid A B 50.779334 
NC 2b Low Mo17 A B 47.491052 
NC 5a High Mo17  B 38.570019 
NC 3b Low hybrid  B 37.541426 
Levels not connected by same letter are significantly different. 
 
(iv) Grain iron bioavailability – New York: There was a strong significant 
difference in grain iron bioavailability among the six genotypes in the New York 
location (P < .0001). Table 3.13 shows least square means differences in grain iron 
bioavailability determined using Tukey HSD. Iron bioavailability of low 
bioavailability potential inbreds and hybrids - 1, 2, 3a and 3b was similar. Iron 
bioavailability of the high bioavailability potential hybrids (sample 6a and 6b) was 
significantly different from that of the inbreds (samples 4 and 5). Comparing inbred 
and hybrid pair lines - samples 1 vs. 4, 2 vs. 5 and 3 vs. 6 - that were expected to have 
different iron bioavailability potentials, the data showed significant differences in iron 
bioavailability only in the hybrid pairs – samples 3 vs. 6. 
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Table 3.13: Least square means differences in grain iron bioavailability (New York) 
 
Level 
Iron bioavailability 
potential 
  
Least Sq 
Mean 
NY 6b High hybrid A  59.430278 
NY 6a High hybrid A  55.778394 
NY 2 Low Mo17  B 39.701743 
NY 3b Low Hybrid  B 37.855076 
NY 5 High Mo17  B 37.714671 
NY 1 Low B73  B 36.388594 
NY 4 High B73  B 31.960686 
NY 3a Low Hybrid  B 29.945763 
Levels not connected by same letter are significantly different. 
 
(v) Grain iron bioavailability – Pennsylvania: There was a significant difference 
in grain iron bioavailability among the six genotypes in the Pennsylvania location (P < 
.0003). Table 3.14 shows least square means differences in grain iron bioavailability 
determined using Tukey HSD. Iron bioavailability of low bioavailability potential 
inbreds (samples 1 and 2) were similar but significantly different from the hybrid 
(sample 3). Iron bioavailability of the high bioavailability potential inbreds and 
hybrids (samples 4, 5 and 6) was not significantly different. Comparing inbred and 
hybrid pair lines - samples 1 vs. 4, 2 vs. 5 and 3 vs. 6 - that were expected to have 
different iron bioavailability potentials, the data showed no significant differences 
between samples. 
 
Table 3.14: Least square means differences in grain iron bioavailability 
(Pennsylvania) 
Level 
Iron bioavailability 
potential 
   Least Sq Mean 
PA 3 Low hybrid A   57.838923 
PA 5 High Mo17 A B  51.332505 
PA 6 High hybrid A B  48.445494 
PA 4 High B73  B C 41.599891 
PA 2 Low Mo17  B C 39.595536 
PA 1 Low B73   C 30.189753 
Levels not connected by same letter are significantly different. 
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Overall, analysis of the individual locations showed the expected trend more in 
superior allele lines (samples 4, 5 and 6) compared to inferior allele lines (samples 1, 2 
and 3). Also, iron bioavailability in Mo17 lines was more to expectation compared to 
B73 lines, which may suggest that B73 lines are more subject to G×E interaction. 
 
(c) Soil Analysis: An important goal in this study was to determine the 
association between soil iron status
 
and both grain iron concentration and amount of 
bioavailable iron from grain samples grown in our selected locations. Table 3.15 
highlights some of the soil data collected in this study. 
 
Table 3.15: Highlights of soil data collected from locations where trials were planted 
Location Soil depth 
(cm) 
Row 
Number 
Extracted Fe 
(mg/kg) 
Total Fe 
(mg/g) 
pH 
NEW YORK 10 40 19.4 8.0 7.5 
NEW YORK 30 40 18.0 8.9 7.9 
NEW YORK 10 80 29.5 8.2 7.7 
NEW YORK 30 80 36.8 7.4 7.8 
NEW YORK 10 120 26.5 7.8 7.5 
NEW YORK 30 120 26.2 7.7 7.8 
NEW YORK 10 180 19.2 7.8 7.6 
NEW YORK 30 180 20.4 7.3 7.7 
NEW YORK 10 221 23.6 7.7 7.6 
NEW YORK 30 221 26.3 7.9 7.8 
NEW YORK 10 261 19.8 7.5 7.6 
NEW YORK 30 261 20.5 7.7 7.8 
IOWA 10 - 47.3 5.2 6.1 
IOWA 30 - 41.5 5.8 6.1 
MISSOURI 10 - 66.1 4.9 6.2 
MISSOURI 30 - 59.0 4.9 6.4 
NCAROLINA 10 - 13.7 1.7 6.3 
NCAROLINA 30 - 18.0 2.4 6.4 
PENNSYLVANIA 10 - 22.6 7.3 6.1 
PENNSYLVANIA 30 - 28.9 7.3 5.7 
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Figure 3.2 shows a one-way analysis of variance (ANOVA) of extracted soil 
iron by location. As shown, there was a significant difference in the amount of 
extracted iron from the five locations (P < .0001). The mean extracted soil iron was 
29.17 mg/kg, and the mean range was 13.7 – 66.1 mg/kg. 
 
One-way ANOVA of soil Extracted iron by Location 
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Figure 3.2: One-way analysis of variance (ANOVA) for iron extracted soil by location. 
Analysis of all pairs was done using Tukey-Kramer (JMP v7). NCAROLINA = North 
Carolina. PENN = Pennsylvania. 
 
Figure 3.3 shows a one-way ANOVA of total soil iron by location. There was 
a significant difference in the amount of total soil iron from the five locations (P < 
.0001). The mean total soil iron was 6.67 mg/g, and the range was 1.7 – 8.9 mg/g. 
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One-way ANOVA of Total soil iron by Location 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: One-way ANOVA for total soil iron by location. Analysis of all pairs was 
done using Tukey-Kramer (JMP v7). NCAROLINA = North Carolina. PENN = Pennsylvania. 
 
Table 3.16 shows pairwise correlations for grain iron concentration, grain iron 
bioavailability, soil extracted iron, total soil iron, and soil pH correlations. The aim of 
the analysis was to determine the association between soil Fe status
 
and both grain iron 
concentration and amount of bioavailable iron from grain samples grown in our 
selected location. The correlation data show a significant but negative correlation 
between total soil iron and grain iron bioavailability. The correlation between soil pH 
and soil extractable iron was also negative and significant, while the correlation 
between soil pH and total soil iron was positive and significant. It is also important to 
note that the correlation between grain iron concentration and grain iron 
bioavailability was small and not significant, while that between total soil iron and 
grain iron concentration was negative though not significant. 
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Table 3.16: Pairwise correlations for grain iron concentration, grain iron 
bioavailability, soil extracted iron, total soil iron and soil pH. 
Variable by Variable Correlation Prob > F 
Grain Fe Bioavailability Grain Fe concentration 0.2187 0.1270 
Total soil Fe Grain Fe concentration -0.0264 0.8555 
Total soil Fe Grain Fe Bioavailability -0.6517 <.0001 
Soil extractable Fe Grain Fe concentration 0.0052 0.9712 
Soil extractable Fe Grain Fe Bioavailability 0.1714 0.2339 
Soil extractable Fe Total soil Fe 0.1811 0.2081 
Soil pH Grain Fe concentration 0.2437 0.0881 
Soil pH Grain Fe Bioavailability -0.0548 0.7053 
Soil pH Total soil Fe 0.3531 0.0119 
Soil pH Soil extractable Fe -0.3127 0.0270 
 
The results presented clearly indicate a significant G×E interaction for both 
grain iron concentration and grain iron bioavailability. 
 
Discussion 
As mentioned earlier, the G×E interaction is a result of inconsistent genotype 
performance across environments. In this study we analyzed the effects of G×E 
interaction on grain iron concentration and grain iron bioavailability for six genotypes 
grown across five diverse locations. If the iron traits were relatively stable across these 
locations, we expected that the expression of iron traits for individual genotypes would 
be consistent across the locations, and the magnitude of difference between genotypes 
or relative ranking of the genotypes within individual locations would similarly be 
consistent. Overall there was a significant effect of G×E interaction for both grain iron 
concentration and grain iron bioavailability. However, a further analysis of G×E 
interaction for grain iron concentration showed that grain iron concentration for 
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genotypes 2 and 5 was consistently expressed across the five locations. In addition, the 
North Carolina location stood out, as there was no significant difference in grain iron 
concentration between the six genotypes grown there. A similar analysis for grain iron 
bioavailability showed no significant difference in grain iron bioavailability among the 
six genotypes grown in the North Carolina location. It is not clear if these results can 
be attributed to soil properties or altitude, but it is worth noting that the North Carolina 
location had the lowest altitude, mean total soil iron, and mean soil extractable iron. 
Another goal of this study was to determine the association between soil iron 
status
 
and both grain iron concentration and amount of bioavailable iron from grain 
samples grown in our selected locations. The data show no significant association 
between soil extractable iron and either grain iron concentration or grain iron 
bioavailability. There was however a highly significant (P<.0001) negative correlation 
between total soil iron and grain iron bioavailability. This may suggest that our maize 
genotypes would express more bioavailable iron if grown in soils that had low or poor 
iron status. This is significant because land owned by poor farmers in target locations 
such as Sub-Saharan Africa is likely to have mineral-deficient soils. 
 
Conclusion 
Micronutrient trait expressions and the extent of G×E interaction across 
diverse environments can influence both screening and breeding methods used in an 
iron biofortification program (Pfeiffer & McClafferty, 2007). The impact of 
biofortified maize on the iron status of those suffering from iron deficiency will 
depend to a large extent on the iron bioavailability of the maize genotypes. Our studies 
have consistently shown no significant association between grain iron concentration 
and grain iron bioavailability (Hoekenga et al, unpublished data). Our screening and 
breeding methodologies have thus been based on grain iron bioavailability. Analysis 
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of grain iron bioavailability shows high G×E interaction. Since the major target areas 
for biofortified crops are located in developing countries, additional progress in 
breeding for iron biofortified maize requires that further breeding and G×E testing be 
carried out in these target locations. 
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CHAPTER 4 
ASSESSMENT OF IRON BIOAVAILABILITY FROM  
IRON BIOFORTIFIED MAIZE 
 
Abstract 
The aim of our study was to use the Caco-2 cell in vitro model and a poultry 
model to test iron bioavailability in two select maize hybrid lines. The Caco-2 cell 
model was used as an initial screening tool to estimate the amount of bioavailable iron 
in the maize hybrid lines. The poultry iron model was used to confirm the in vitro 
results and validate the breeding method employed in iron biofortification of the 
hybrids. The Caco-2 cell bioassay data showed that the amount of bioavailable iron 
differed significantly (P =.0014) in the two hybrid lines. The maize lines were then 
used to formulate nutritionally balanced chicken diets (except for iron) that were fed 
ad libitum to day-old Cornish Cross broiler chicks for 4 weeks. Feed intakes were 
measured daily while weight and hemoglobin (Hb) were monitored weekly. Hb values 
were used to estimate iron bioavailability from the diets. Although iron concentrations 
in the two diets were similar (high bioavailability maize diet = 24.79±0.70 ppm and 
low bioavailability maize diet = 24.39±0.32 ppm), significant differences in blood Hb 
concentrations were observed between chicks consuming the two diets (P = .0004). 
We conclude that conventional breeding can improve iron nutritional quality in maize 
grain, thus providing significantly more bioavailable iron to growing chicks. Human 
feeding trials should be conducted to determine the efficacy
 
of consuming the high 
bioavailable iron maize.  
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Introduction 
Iron deficiency is the most widespread micronutrient deficiency in the world, 
affecting approximately two billion people (Zimmermann & Hurrell, 2007). The 
causal factors responsible for iron deficiency across the globe are complex and multi-
factorial, but its root cause is thought to be the prevalence of dysfunctional food 
systems that fall short of delivering sufficient micronutrients to meet human 
requirements (Welch & Graham, 2005). The consequences of iron deficiency anemia 
(IDA) include impaired growth, retarded psychomotor and cognitive development in 
children, damaged immune mechanisms with increased morbidity and mortality rates 
in all age groups, and reduced work capacity in adults (WHO, 2001; Neumann, Gewa, 
& Bwibo, 2004). 
The traditional strategies that have been employed to address IDA include 
dietary diversification, iron supplementation, and food fortification. Dietary 
diversification is an ideal approach that aims to improve iron intake and bioavailability 
but requires an educational component to achieve the desired changes in dietary 
behaviors. Iron supplementation is a therapeutic strategy aimed at groups that are 
highly susceptible to IDA. However, logistical constraints such as poor infrastructure 
and poor compliance at the individual level can reduce the effectiveness of 
supplementation (Zimmermann & Hurrell, 2007). In addition, recent studies show that 
untargeted iron supplementation in children living in regions to which malaria is 
endemic may result in increased risk of morbidity and mortality (Sazawal et al., 2006). 
On the other hand, iron fortification of foods is a practical and cost-effective 
prophylactic approach to iron deficiency and anemia. Nevertheless, in populations 
with limited access to fortified foods it is less effective (Zimmermann & Hurrell, 
2007). These traditional strategies have had some success in reducing the burden of 
IDA in some populations.  
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In 1995, the Consultative Group on International Agriculture Research 
(CGIAR) initiated a micronutrients project that focused on linking agriculture and 
nutrition through ―biofortification‖ of staple food crops (Graham, Welch & Bouis, 
2001). Biofortification is defined as the process of breeding improved food crops that 
are rich in bioavailable iron, beta carotene and/or zinc. Biofortification of staple foods 
is thought to be a potential complementary strategy for alleviating IDA in at-risk 
populations, and it presents a number of advantages, especially the potential for 
providing more micronutrients at an affordable cost via the agricultural system. Thus, 
by targeting resource-poor populations that grow and consume their own food, the 
biofortification strategy would more effectively reach populations with limited access 
to diet diversification, iron fortification, or supplementation (Nestle et al., 2006; 
Mayer, Pfeiffer & Beyer, 2008). 
Successful micronutrient biofortification requires, of course, that nutritionally 
improved crop lines be efficacious (Welch & Graham, 2004; Nestle et al., 2006). 
Simply increasing iron concentration in a staple food like maize does not necessarily 
reduce IDA incidence because this does not necessarily enhance bioavailability (Borg 
et al., 2009). Because the importance of bioavailability in the uptake of micronutrients 
such as iron is widely recognized, bioavailability studies will play a key role in 
assessing the biofortification process (Welch et al, 2000). The ideal approach would 
be to conduct iron bioavailability studies in humans. Such studies are, however, 
extremely
 
expensive and often require refinement of objectives via appropriate in vitro 
and in vivo animal
 
iron models in order to ensure success. 
A number of in vitro and in vivo animal models are available for determining 
iron bioavailability (Wienk, Marx & Beynen, 1999). In vitro methods provide an 
attractive,
 
rapid, and low-cost option for initial screening of iron bioavailability. 
Solubility and dialyzability are in vitro techniques that have previously been used to 
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predict iron bioavailability. They do not, however, measure iron bioavailability 
completely, greatly diminishing their usefulness (Fairweather-Tait et al, 2007; Miller 
& Berner 1989). The development of an in vitro iron bioavailability model that 
mimics the gastric and intestinal digestion of humans, coupled with cultures of human 
Caco-2 cells, has shown great promise in addressing iron bioavailability issues (Yun et 
al., 2004; Au & Reddy, 2000; Glahn et al., 1998). The in vitro digestion/Caco-2 cell 
iron model has been used in previous studies to predict iron bioavailability, and was 
used in this study as a screening tool (Glahn et al., 2002; Pynaert et al., 2006). 
In vivo animal models are very useful in studying the mechanism of iron 
absorption and understanding iron bioavailability. Rodents and more recently piglets 
have been the models of choice for iron bioavailability studies. Although similarities 
in gastrointestinal anatomy and physiology between pigs and humans attract 
researchers to that model, the large size of pigs makes it an expensive model to 
employ. The rat model is relatively less expensive but may not be ideal given that rats 
are much more efficient at absorbing iron than are humans (Welch et al., 2000). The 
poultry model has been used effectively in some iron bioavailability studies (Wienk, 
Marx & Beynen, 1999), and has been proposed as a suitable in vivo model for iron 
bioavailability (Tako, Rutzke & Glahn, 2010). The poultry model was thus adopted for 
initial screening of biofortified maize in this study because it has been shown to 
respond appropriately to differences in iron bioavailability in foods. In addition, a 
feeding trial using the poultry model can accommodate modest amounts of sample 
material produced by breeders with restricted plot sizes or in the initial stages of a 
biofortification project. 
The focus of our project has been iron biofortification in maize. This chapter 
evaluates two hybrid maize lines that were identified during the genotype screening 
process using the Caco-2 cell model, with the expectation that they would have 
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significant differences in iron nutritional quality while being largely similar in other 
respects. We present results from the Caco-2 cell assay and a 4-week poultry feeding 
trial. The goal of this chapter is to validate the quantitative trait loci (QTL) approach 
for iron bioavailability while addressing the following question: Are significant 
differences in iron bioavailability between the hybrids as seen in the in vitro 
digestion/Caco-2 cell iron model reflected in the in vivo poultry model? 
 
Materials and Methods 
Chemicals, enzymes, and hormones: Unless otherwise stated, all chemicals, 
enzymes, and hormones were purchased from Sigma Chemicals Co. To prepare 
reagents for cell culture, 18 MΩ water was used. Glassware and utensils used in the 
experiments were soaked in 1.2 M HCl for at least 4 hours and rinsed in deionized 
water prior to use. 
Maize samples: The two maize varieties tested in the poultry feeding trial are 
derived from the Intermated B73 x Mo17 (IBM) recombinant inbred (RI) maize 
population. These lines were selected for the poultry feeding trial based on their 
parents‘ Caco-2 cell assay data. The parents are near isogenic line sister pairs (more 
that 90% genetically identical to each other) that were isolated from a Caco-2 cell 
assay screening of 54 maize lines planted in 2007 on a Cornell University research 
farm in Aurora, NY (see Figure 4.1). The parental genotypes that exhibited high 
bioavailability potential (high bioavailability B73; C-025 and high bioavailability 
Mo17; C-052) were crossed to produce a daughter genotype referred to in the data as 
the High×High hybrid. The parental genotypes that exhibited low bioavailability 
potential (low bioavailability B73; C-028 and low bioavailability Mo17; C-030) were 
crossed to produce a daughter genotype is referred to in the data as the Low×Low 
hybrid. For the poultry feeding trial, the High×High hybrid forms the Group H diet—
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the high bioavailability maize diet— and the Low×Low hybrid forms the Group L 
diet—the low bioavailability maize diet. The maize lines were bred via conventional 
breeding guided by the Caco-2 cell/ quantitative trait loci (QTL) model. 
  
  Oneway Analysis of Bioavailable Fe (% of control) By Sample 
 
 
 
 
 
 
 
 
 
Figure 4.1: One way analysis of bioavailable iron in inbred parents of hybrids tested 
in the poultry feeding trial. The parental genotypes that exhibited high bioavailability 
potential were high bioavailability B73 (HB) C-025 and high bioavailability Mo17 
(HM) C-052. The parental genotypes that exhibited low bioavailability potential were 
low bioavailability B73 (LB) C-028 and low bioavailability Mo17 (LM) C-030. The 
high bioavailability inbreds had significantly more bioavailable iron than the low 
bioavailable inbreds (P < .0001). HB and HM were crossed to produce a High×High 
hybrid. LB and LM were crossed to produce a Low×Low hybrid. 
 
Maize sample preparation: Maize kernels (20g) were sorted to remove any 
debris or damaged seeds and then placed in a 50 mL centrifuge tube and covered with 
25 mL of 18 MΩ water. Samples were then autoclaved at 121 C and at a pressure of 
115 kPa for 40 min, allowed to cool at room temperature, and then frozen overnight at 
–20 C. Samples were then freeze-dried at 100 millTorr and a temperature of –50 C 
for 7 days, ground to a fine powder with a coffee mill (90 sec), and stored in 50 mL 
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centrifuge tubes at 25 C. A tamale maize sample, used as a control in the Caco-2 cell 
bioassay, was prepared in an identical manner. 
Mineral analysis for maize and liver samples: A 0.3g dry ground maize sample 
or a 0.4 g chicken liver tissue sample was weighed into borosilicate glass test tubes 
and chemically digested using 4 mL of concentrated nitric acid at 120 C until the 
residue was light brown to yellow in color. Exactly 1.0 ml of a 50/50 mixture of 
concentrated nitric acid and perchloric acid was then added, and the temperature was 
increased to 180 C. After 2 hours, the temperature was further increased to 240 C 
until the digested samples were dry. After cooling, 0.25 mL of concentrated 
hydrochloric acid was added to dissolve the ash. One hour later, the sample was 
diluted with 10 mL of 5% nitric acid. The ashed sample was then mixed and 
transferred into 15 mL auto sampler tubes and analyzed on an axially viewed 
inductively coupled plasma (ICP) trace analyzer emission spectrometer (model ICAP 
61E trace analyzer, Thermo Electron, Waltham, MA; see Rutzke, 2002). 
Caco-2 cell screening: The in vitro Caco-2 cell iron model was used as a 
screening tool to estimate the amount of bioavailable iron in the maize samples. 
Cell Culture: Caco-2 cells were obtained from the American Type Culture 
Collection (Rockville, MD) at passage 17 and used in experiments at passages 25–33. 
Cells were seeded at a density of 50,000 cells/cm
2
 in collagen-treated six-well plates 
(Costar Corp., Cambridge, MA). The cells were grown in Dulbecco‘s Modified Eagle 
Medium (GIBCO, Grand Island, NY) with 10% v/v fetal calf serum (GIBCO), 25 
mmol/L N-(2-Hydroxyethyl) piperazine-N‘-2-ethane sulfonic acid (HEPES), and 1% 
antibiotic antimycotic solution (GIBCO). The cells were maintained at 37 C in an 
incubator with a 5% CO2/95% air atmosphere at constant humidity, and the medium 
was changed every 2 days. The cells were used in the iron uptake experiments at 13 
days post seeding. 
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In Vitro Digestion: The preparation of the digestion solutions—pepsin, 
pancreatin, and bile extract—and the in vitro digestion was performed as previously 
published (Glahn et al., 1998). Briefly, 1.0 g of dry samples was used for each sample 
digestion. Ascorbic acid (AA) was added to enhance iron bioavailability using a 20:1 
AA: Fe molar ratio. Then 10 ml of pH 2 140 mM NaCl, 5 mM KCl buffer was added 
to the samples, and the mixture was pH re-adjusted to pH 2. Then 0.5 mL of pepsin 
solution was added to each of the samples prior to incubation. After a 1-hour 
incubation, the sample pH was adjusted to pH 5.5 to 6.0 with 1.0 M NaHCO3, and 
after the addition of 2.5 mL of pancreatin-bile solution, the sample pH was further 
adjusted to pH 6.9-7.0 with 1.0 M NaHCO3. Sample volumes were then adjusted (by 
weight) to tube weight plus 15 g using the 140 mM NaCl, 5 mM KCl pH 6.7. Finally, 
1.5 mL of the samples was transferred to appropriate inserts on the Caco-2 cell plates. 
Harvesting: The harvesting of the Caco-2 cell monolayers was performed as 
previously published (Glahn et al., 1998). The cells were harvested after a 24-hour 
incubation period. First, growth media were carefully aspirated off the cells. The cells 
were then rinsed twice with 2 mL of 130mM NaCl, 5 mM PIPES, pH 6.7 buffer. To 
harvest the cells, 2 mL of 18.2 M  water was added to the cells, and the cells were 
placed in a sonicator (Lab-line Instruments, Melrose Park, IL) at 4 C for 15 minutes. 
The cells were then scraped off the plates, suspended in the 2 mL of 18.2 M  water, 
and transferred to pre-labeled 5 ml tubes in anticipation of protein and ferritin assays. 
Cell Protein Analysis: Caco-2 cell protein was measured on samples that had 
been solubilized in 0.5 mol/L NaOH, using a semimicro adaptation of the Bio-Rad DC 
protein assay kit (Bio-Rad Laboratories, Hercules, CA). A 25 L sample of the 
sonicated Caco-2 cell monolayer, harvested in 2 mL of water, was used for each 
protein measurement expressed in mg. 
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Ferritin Analysis: A one-stage, two-site immunoradiometric assay was used to 
measure Caco-2 cell ferritin content (FER-Iron II Ferritin Assay, RAMCO 
Laboratories, Houston, TX). A 10 L sample of the sonicated Caco-2 cell monolayer, 
harvested in 2 mL of water, was used for each ferritin measurement expressed per unit 
cell protein (ng ferritin/mg cell protein). 
Poultry Feeding Trial: The in vivo poultry model was used to estimate iron 
bioavailability in the two maize samples. The experiment was conducted at the Cornell 
University Poultry farm in Ithaca, NY. All animal protocols were approved by the 
Cornell University Institutional Animal Care and Use Committee. Figure 4.2 shows an 
overview of the study design. 
Subjects: Fertile chicken eggs were incubated for 21 days before hatching. 
Seventeen day-old Cornish Cross broiler chicks were then randomized based on 
weight, into three groups—6 chicks in each of the 2 study groups, and 5 chicks in the 
positive-control group. Each group was housed in a temperature-controlled metabolic 
cage on a 12-hour light/dark cycle. 
Diet and diet administration: The chicks were introduced to the experimental 
diet immediately after hatching and allowed ad libitum feed and water intake. Maize 
iron and phytate concentration, and diet composition and iron concentration are shown 
in Table 4.1. 
 
 
 
 
 9
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  Figure 4.2: Overview of the study design 
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Data and tissue collection: As highlighted in Figure 4.1, feed intake data were 
collected daily. Body weight and blood samples were taken at baseline, then weekly 
for 4 weeks. At the end of the study, liver tissue was also sampled. 
Hemoglobin (Hb) measurements: Blood Hb concentrations were determined 
using the cyanmethemoglobin method following the manufacturer‘s kit instructions. 
Hb values were used in this study to calculate total body hemoglobin iron and 
hemoglobin maintenance efficiency values for the chickens in the feeding trial. 
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Table 4.1: Diet composition and iron concentration data for poultry trial 
Ingredient Group H Group L Group C 
 g/kg diet 
Ground maize
1
 750 750 750 
Choline Chloride 0.75 0.75 0.75 
Maize oil 30 mL 30 mL 30 mL 
Maize starch 46.25 46.25 46.25 
DL-Methionine 2.5 2.5 2.5 
Dry skim milk 100 100 100 
Ferric citrate - - 0.5 
Vitamin/Mineral premix (no iron)
2
 70 70 70 
                                                               Iron & Phytate concentrations 
Iron in maize (ppm) 
Mean ± SD, n= 3 
21.23±0.23 18.79±0.41 18.07±1.04 
Iron in diet (ppm) 
Mean ± SD, n= 3 
24.79±0.70 24.39±0.32 116.54±2.49 
Phytate in maize (µmoles/g) 
Mean ± SD, n= 2 
10.88±0.08 10.28±0.08 - 
1
Ground maize—group H: high bioavailability hybrid maize (cooked); group L: low 
bioavailability hybrid maize (cooked); group C (Positive-control group): commercially 
purchased maize (uncooked). 
2
A vitamin/mineral premix was purchased from Dyets, Inc (Bethlehem, PA). The 
premix provided (per kg diet): retinyl palmitate, 1208 µg; ergocalciferol, 5.5 µg; dl- -
tocopheryl acetate, 10.72 mg; menadione, 0.5 mg; d-biotin, 0.05 mg; choline chloride, 
0.5 g; folic acid, 0.3 mg; niacin, 15 mg; Ca-D panthothenate, 10 mg; riboflavin, 3.5 
mg; thiamin, 1 mg; pyridoxine, 1.5 mg; cyanocobalamin, 17.5 µg; CuSO4·5H2O, 6 
mg; C2H8N2·2HI (ethylene diamine dihydroiodine), 0.14 mg; MnO, 4 mg; Na2SeO3, 
0.3 mg; ZnO, 100 mg. 
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Total body hemoglobin iron (Hb Fe): Total body hemoglobin iron for each 
chick was calculated from body weight (BW), Hb concentration and estimated blood 
volume using the following formula:  
Hb Fe = BW (kg) × [0.06 L blood/kg BW] × Hb (g/L blood) × [3.35 mg Fe/g Hb] 
Hemoglobin maintenance efficiency (HME): Hemoglobin maintenance 
efficiency values were calculated as follows: 
HME = Hb Fe, mg (final) – Hb Fe, mg (initial) × 100% 
                          Total Fe intake, mg 
Statistical Analyses: Statistical analyses of the data were performed using the 
GraphPad Prism v4 (GraphPad Software, San Diego, CA) and JMP v7.0 (SAS 
Institute Inc., Cary, NC) software packages. Repeated measures analysis was done for 
all repeated measurements. In some cases, the data were log-transformed prior to 
analysis. Means were considered to be significantly different for P values 0.05. 
 
Results 
The initial screening of the maize hybrid lines using the Caco-2 cell bioassay 
showed significant differences between varieties. The goal of our study was to 
establish if the differences seen in the in vivo iron model would be evident in the avian 
model. In this study we analyzed two near isogenic hybrid lines derived from the IBM 
RI maize population. The hybrids were identical essentially everywhere except for the 
iron grain bioavailability QTL where they had either all superior or inferior alleles. 
Here we present results from the Caco-2 cell bioassay and the poultry feeding trial. 
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(a) Caco-2 cell experiment 
Figure 4.3 shows in vitro estimates of the amount of bioavailable iron (ng/mg) 
in the daughter hybrid lines. As in the parental lines, the amount of bioavailable iron in 
vitro was significantly different between the daughter hybrid lines (P =.0014). 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Caco-2 cell ferritin formation. The amount of bioavailable iron in maize 
hybrids (daughter lines) was assessed with the use of the Caco-2 cell model. Ferritin 
formation in the cells is an index of iron bioavailability. One gram (dry weight) of 
each sample was analyzed in the model. Statistical analysis was performed by one-
way ANOVA and student‘s t test. Column values (mean ± SEM, n = 6) with no letters 
in common are significantly different (P < 0.05). 
 
(b) Poultry Feeding Trial 
(i) Feed intake, Daily iron intake, and Body weight: The cumulative feed 
intake, mean daily iron intake, and body weight development of the chicks are 
summarized in Table 4.2. 
Feed intake: Statistical analysis revealed that there was a week-and-diet effect 
on feed intake but no interaction (diet × week) effect. Throughout the study, feed 
intake was lowest in Group C and this differed significantly from that measured in 
Caco-2 cell iron uptake
High X High hybrid Low X Low hybrid 
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Groups H and L (P <.0001). However, feed intake increased consistently in all three 
groups during the study, and feed intake for each week was significantly different 
from that of every other week (P <.0001). 
 
Table 4.2: Cumulative feed intake, daily iron intake, and body weight of the chicks.  
 
Study week 
 Week 1 Week 2 Week 3 Week 4 
 Feed intake (g) 
Group 
H
3
 
378.3±24.84
dα
 773.6±16.59
cα
 1235.8±27.12
bα
 1732.9±23.40
*aα
 
Group L 402.0±28.28
dα
 817.4± 11.57
cα
 1125.9± 20.05
bα
 1569.5± 24.71
aα
 
Group C 314.1± 9.82
dβ
 550.2± 8.30
cβ
 858.2± 20.86
bβ
 1436.2±34.21
aβ
 
  Week 1 Week 2 Week 3 Week 4 
 Daily iron intake (mg)
1
 
Group H 1.56 ± 0.62
dβ
 2.74 ± 0.4
cβ
 4.38 ± 0.67
bβ
 6.14 ± 0.58
aβ
 
Group L 1.63 ± 0.69
dβ
 2.85 ± 0.28
cβ
 3.92 ± 0.49
bβ
 5.47 ± 0.60
aβ
 
Group C 6.10 ± 1.14
dα
 9.16 ± 0.97
cα
 14.29 ± 2.43
bα
 23.91± 3.99
aα
 
 
 Week 1 Week 2 Week 3 Week 4 
 Body weight (g)
1
 
Group H 89.65±24.08
dα
 150.90±55.86
cα
 256.55±106.81
bα
 382.24±102.68
aα
 
Group L 91.03± 8.68
dα
 142.42±44.95
cα
 223.07± 102.65
bα
 303.07±166.39
aα
 
Group C 77.02± 5.38
dα
 119.30±28.13
cα
 180.66± 72.00
bα
 237.08±112.17
aα
 
1
Mean±SD. 
2
 Values in same row (English alphabet)/column (Greek alphabet) with different 
superscript letters are significantly different; (P < 0.05). 
3
Group H (n = 6): High bioavailability maize diet, Group L (n = 6): low 
bioavailability maize diet, Group C (n = 5): Positive-control maize diet, 
*
1 mortality. 
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Daily iron intake: Daily iron intake values were computed from daily feed 
intake and diet iron concentration data. Group C had the highest daily iron intake, 
which was significantly different from that of Groups H and L (P <.0001). Daily iron 
intake did increase consistently in all three groups during the study and each week‘s 
result was significantly different from that of every other week (P <.0001). 
Body weight: The chicks grew well over the course of the study. Body weight 
was not significantly different by treatment or diet (P = .3250) but was significantly 
different by time (P <.0001). 
 
(ii) Hemoglobin, Liver iron concentration, Hemoglobin iron and 
Hemoglobin maintenance efficiency: Hemoglobin, liver iron concentration, total 
body hemoglobin iron and hemoglobin maintenance efficiency are shown in Figure 
4.4, Figure 4.5, Table 4.3 and Figure 4.6 respectively.  
 
Hemoglobin: After an initial dip in hemoglobin (Hb) concentration, from day 8 
on, chicks in Groups H and C showed an increase in Hb concentration, which leveled 
off by the end of the study. However, chicks in Group L showed a steady decline in 
Hb concentration (Figure 4.4). There was a strong diet and week effect on Hb 
concentration.  Hb concentration in Groups H and C was significantly different from 
Group L (P = .0004) and Hb concentration differed significantly across weeks 2, 3 and 
4 (P <.0001). 
 
 1
0
1
 
 
Figure 4.4: Hemoglobin trend during the poultry feeding trial. Blood samples were collected at baseline, day 8, day 15, day 
22 and day 28, and hemoglobin concentration (Hb) analyzed using the cyanmethemoglobin method. Statistical analysis was 
performed by repeated measures ANOVA. Hb concentration in Groups H and C was significantly different from Group L 
(P = .0004). Hb concentration for weeks 2, 3 and 4 were significantly different from each other (P <.0001). Hb values 
(mean ± SEM). Group H [n = 6 (n = 5 on day 28)]: High bioavailability maize diet, Group L (n = 6): low bioavailability 
maize diet, Group C (n = 5): Positive-control maize diet.  
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Liver iron concentration: Liver iron concentration data are shown in Figure 
4.5. Chicken livers were harvested at the end of the study and analyzed for iron 
concentration by ICP-ES. Liver iron was highest in Group C, and differed 
significantly (P <.0001) across all groups.  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Liver iron concentration. Chicken livers were harvested on day 28 of 
study and iron concentration determined using ICP-ES. 0.4 grams (wet weight) of 
each sample (n=3) was analyzed. Statistical analysis was performed by Tukeys-HSD. 
Bar values (mean ± SEM) with no letters in common are significantly different (p < 
0.05). Group H (n=5): High bioavailability maize diet, Group L (n=6): low 
bioavailability maize diet, Group C (n=5): Positive-control maize diet. 
 
Total body hemoglobin iron (Hb Fe): As seen in Table 4.3, Group H had relatively 
higher body Hb Fe during the study, which was significantly different from Groups L 
and C (P =.0023). Body Hb Fe was also significantly different between weeks (P 
<.0001) with weeks 3 and 4 being significantly different from week 1 and 2, and week 
1 being significantly different from week 2. 
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Table 4.3:  Total body hemoglobin iron 
 Study day  
 
Baseline Week 1 Week 2 Week 3 Week 4 
 Hb Fe (mg)
 
  
Group H3 - 1.83±0.49
cα
  3.53± 1.53
bα
 5.33±2.09
aα
 7.65 ±1.82
aα*
 
Group L - 1.71± 0.16
cβ
 2.30±0.61
bβ
 3.43±1.47
aβ
 4.30±2.26
aβ
 
Group C - 1.50± 0.10
 cβ
 2.71±0.90
bβ
 3.81±1.76
aβ
 4.76±2.25
aβ
 
1
Mean±SD. 
2
 Values in same row (English alphabet) /column (Greek alphabet) with different 
superscript letters are significantly different; (p < 0.05).  
3
Group H (n=6): High bioavailability maize diet, Group L (n=6): low bioavailability 
maize diet, Group C (n=5): Positive-control maize diet. 
*
1 mortality 
 
Hemoglobin maintenance efficiency (HME): HME provides an estimate of the 
percentage of ingested iron that is absorbed and utilized to maintain hemoglobin 
synthesis and the values were calculated using data collected during week 1, 2, 3 and 
4.  It is a slight underestimate because some of absorbed iron is incorporated into 
myoglobin and other iron containing proteins and some is excreted. HME values for 
Group H were significantly different from Group L (P < .0001), and differed across 
weeks (P = 0.0147, see Figure 4.6). Because the goal of this study was to compare the 
high bioavailable iron maize with the low bioavailable iron maize, only data from 
these two groups are presented in Figure 4.6. 
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Figure 4.6: Hemoglobin maintenance efficiency values. HME values for Group H were significantly different from those of 
Group L (P < .0001), and differed across weeks (P = 0.0147). Values (mean ± SEM). Group H [n = 6 (n = 5 on day 28)]: 
High bioavailability maize diet, Group L (n = 6): low bioavailability maize diet. 
 
Weeks on diet 
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Discussion 
This chapter presents results collected on the bioavailability of iron in two 
maize hybrids grown under field conditions in Poplar Ridge, New York. The maize 
samples were selected for the poultry feeding trial based on the bioavailability 
potential of their parents—high bioavailability maize vs. low bioavailability maize. 
The daughter lines showed the same pattern in the Caco-2 cell model (Figure 4.3) and 
were therefore formulated into nutritionally balanced diets (except for iron) for a 
poultry feeding trial. 
Our goal with the poultry feeding trial was to confirm the in vitro results and 
validate the utility of the Caco-2 cell bioassay as a screening tool for use in maize 
improvement programs. The chicken diets were formulated so that for the two 
experimental diets—the high bioavailability maize diet and the low bioavailability 
maize diet—the maize component would provide most of the iron to the growing 
chicks. The control group was a positive control group, which served as an 
experimental reference. The control diet was formulated according to National 
Research Council (NRC) standards and a 0.5 g ferric citrate/kg diet was added to the 
formula to provide additional iron to the chicks.  
Although the two experimental diets exhibited similar levels of iron 
concentration, as shown in Table 4.1, Hb concentration in blood collected from chicks 
in the high bioavailability maize diet (Group H) differed significantly from that of the 
chicks in the low bioavailability maize diet (Group L; P = .0004) during the course of 
the study (weeks 2, 3, and 4; P <.0001). No significant differences were observed 
between the high bioavailability maize diet (Group H) and the positive control group 
(Group C) for blood Hb despite the differences in diet iron concentration. Group C 
diet had a higher iron concentration (116.54 ppm) compared to the Group H diet 
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(24.79 ppm). This would suggest that absorption of iron citrate is different from the 
absorption of native iron. 
In addition, liver iron concentration was used to expand the bioavailability 
data. As shown in Figure 4.5, liver iron values for the groups were significantly 
different (P <.0001). The positive control group (Group C) had the highest liver iron 
concentration, which indicates more storage iron compared to the other two groups. 
Iron intake was similar between the high bioavailability maize diet (Group H) and the 
low bioavailability maize diet (Group L), yet liver iron was significantly different 
between the two groups. This would suggest that the high bioavailability maize diet 
provided more bioavailable iron to the chicks than the low bioavailability maize diet. 
The hemoglobin maintenance efficiency (HME) values were another piece of 
data that demonstrated that the iron in the high bioavailability maize diet is more 
bioavailable than that in the low bioavailability maize diet. As seen in Figure 4.6, 
HME values for Group H were significantly different from Group L (P < .0001). The 
two diets - the high bioavailability maize diet (Group H) and the low bioavailability 
maize diet (Group L) - had the same iron concentrations, but different amounts of 
absorbed iron as shown by the hemoglobin data. The two maize lines were identical in 
every respect except for their iron grain bioavailability alleles. The high bioavailability 
maize line had superior alleles while the low bioavailability maize line had inferior 
alleles. It is plausible that the difference in the amount of bioavailable iron in the two 
hybrids lines can be attributed to either the presence of iron promoter compounds in 
the high bioavailability maize hybrid line or the presence iron inhibitory compounds in 
the low bioavailability maize hybrid line or both. Further research is needed to identify 
and isolate the compounds. 
As already defined, biofortification is the process of enriching the nutrient 
quality of staple food crops via plant breeding or biotechnology. Biofortification as an 
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agricultural intervention has the potential to provide a sustainable solution to 
populations who are at high risk of micronutrient malnutrition. The success of such a 
strategy requires, however, that the nutrients in food crops be bioavailable. Iron is a 
critical nutrient in the diet as it plays a fundamental role in oxygen transport and 
energy metabolism. However, the bioavailability of non-heme iron from plant foods is 
influenced and hindered by many factors. Thus it is vital that the potential 
enhancement of iron nutritional quality in foods include bioavailability testing. 
Crop improvement activities in conventional breeding can produce a vast 
amount of varieties. The same is true of iron biofortification in maize. Therefore in 
order to rank samples, or determine which plant lines have potential or show promise 
for enhanced iron content or quality, a screening method is required. The Caco-2 cell 
iron model has been used as a screening bioassay for in vitro assessment of the amount 
of bioavailable iron in numerous studies and was likewise used in our study to conduct 
the initial screening of the maize lines. One objective for the poultry feeding trial was 
to confirm the in vitro results. The agreement between the in vivo and in vitro data 
therefore validates the Caco-2 cell bioassay as a screening method for iron biofortified 
maize. 
Another objective of the study was to validate the breeding method employed 
in iron biofortification of the hybrids. Genotype data generated from the QTL model 
indicated that the two hybrid lines were dissimilar, exhibiting different bioavailability 
potentials. This was reflected in both the Caco-2 cell data and the poultry feeding trial 
data. All three data sets are in agreement, which validates the QTL model. These 
results are a clear indication that iron biofortification of maize is feasible. 
Previous iron bioavailability studies on iron biofortified staple foods have been 
very successful and have paved the way for subsequent research. A case in point is the 
study of iron bioavailability from iron biofortified rice. The initial screening of the 
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enriched lines was done using a rat model (Welch et al., 2000). In their study, Welch 
et al. identified a rice genotype—IR68144—developed at the International Rice 
Research Institute (IRRI) to be of special interest. Based on these results, Hass et al. 
(2005) conducted a human efficacy trial designed to test the biological effects of 
consuming
 
the biofortified rice. The results from a 9-month human feeding trial 
provided the first indication that breeding for enhanced micronutrient content can 
result
 
in a measurable improvement in nutritional status. Our initial efforts toward 
breeding for improved iron quality in maize have been encouraging. However, a 
human feeding trial similar to the one conducted by Haas et al. is required to further 
validate the QTL breeding
 
strategy and to determine whether iron biofortification in 
maize is a practical and sustainable strategy for mitigating iron malnutrition in at-risk 
populations. 
Conclusion 
Iron deficiency is a worldwide, endemic public health problem. Food-system-
based
 
interventions such as biofortification may provide a practical and sustainable 
solution for at-risk populations. If biofortification is to succeed, however, enriched 
nutrients in foods must be bioavailable. Bioavailability testing is thus an essential 
aspect of the biofortification process. The in vivo results presented in this chapter 
using two selected maize hybrid genotypes show that conventional breeding can 
improve the iron quality in maize, thus providing significantly more bioavailable iron 
to growing chicks. These findings support the biofortification strategy for iron in 
maize but a human feeding trial is required to confirm the efficacy of the iron 
biofortified lines and should thus be prioritized. 
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CHAPTER 5 
A CONCEPTUAL FRAMEWORK FOR BIOFORTIFICATION 
 
Despite advances in science and medicine, micronutrient deficiencies, 
including iron deficiency (ID), still affect over two billion people globally 
(Zimmermann & Hurrell, 2007; WHO, 2001). From a purely food policy perspective, 
there are three questions that must be answered if we are to understand better why 
nutritional iron deficiency persists, especially in developing nations: 1) Who suffers 
from iron deficiency? 2) Where are they located? 3) Why are they still suffering? In 
many developing countries, populations at risk of developing iron deficiency are 
usually economically poor. They comprise predominantly women of child-bearing 
age, infants, and children. A majority reside in rural areas, where they grow their own 
food and consume mainly what they produce. These populations are forced to rely on 
dysfunctional food systems that fail to provide adequate quantities of the nutrients 
they need. Under such conditions, nutritional deficiencies are inevitable. 
In their quest to address micronutrient deficiencies, including ID, nutritionists 
have focused on interventions such as diet diversification, supplementation as well as 
food fortification. And although agriculture is the principal source of nutrients that 
sustain human life, its role in addressing human nutrition issues, including nutrient 
deficiencies, has not been fully exploited until recent years (Pinstrup-Andersen, 2000). 
The emergence of biofortification as an agricultural intervention to address 
micronutrient deficiencies among the rural poor who grow and consume their own 
staple foods has provided the opportunity for a new paradigm for world agriculture 
(Welch & Graham, 2000). The main advantage of biofortification is that it is a 
sustainable approach that can complement traditional food-based approaches for 
addressing micronutrient malnutrition. 
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Traditional interventions—diet diversification, supplementation, and food 
fortification—have helped reduced the burden of iron deficiency, especially in 
developed countries. The advantage of these interventions is that we have reliable 
information about their implementation, efficacy, sustainability, and impact in 
different parts of the world. Therefore they are safe and easy options in programs 
designed to address micronutrient deficiencies. These interventions have, however, 
produced relatively better results in developed countries than in developing countries. 
Factors such as poor infrastructure, the need for centralized processing, limited human 
resources, lack of financial resources, and lack of political will have resulted in limited 
success in developing countries. In developing countries in which these interventions 
have had some success, the urban population is usually better placed to benefit from 
such intervention programs, leaving the rural poor sidelined with little benefit from 
traditional interventions. Biofortification of staple foods can help bridge this gap by 
directly targeting the rural poor, especially those who grow and consume their own 
foods.  
As shown in the conceptual framework (Figure 5.1), biofortification has the 
potential to more effectively address iron deficiency among at-risk populations 
because it addresses the root cause of the problem. If properly implemented, iron 
biofortification of staple foods can result in increased iron intake or bioavailability that 
can help increase body iron and maintain iron status for non-anemic individuals (Haas 
et al, 2005). On the other hand, when coupled with other interventions such as 
supplementation or post-harvest fortification, it is plausible that biofortification can 
help improve the iron status of previously anemic individuals and help maintain 
normal iron status (Bouis &Welch, 2010). 
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Figure 5.1: Conceptual framework for biofortification. 
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Farmer adoption and consumer acceptance are critical to the success of 
biofortification (Welch & Graham, 2004). However, upstream research is equally 
important. This research work has focused on three important goals: 1) to determine if 
both iron concentration and iron bioavailability in maize are genetically tractable 
traits, 2) to evaluate the magnitude of Genotype x Environment interaction in 
biofortified maize, and 3) to assess iron bioavailability from iron biofortified maize. 
Table 5.1 provides a summary of the research conducted and lessons learned. 
The ultimate goal of our biofortification project should be to create elite maize 
lines that can be adopted by farmers and accepted by consumers in target regions such 
as Sub-Saharan Africa, where iron deficiency and anemia are significant public health 
problems. The maize lines produced must therefore have excellent agronomical 
qualities and be effective in reducing iron deficiency. Our research work, presented in 
three studies (chapters 2–4), has highlighted a conventional breeding method—the 
Caco-2 cell/QTL approach—that can be used to breed for enhanced iron 
bioavailability in maize. We have also stressed the need to assess Genotype x 
Environment interaction and shown proof of concept that conventionally bred iron 
biofortified maize provides significantly more bioavailable iron to growing chicks. 
The next step in the research work can be similarly study-specific, as shown: 
Study 1: Enhancing iron bioavailability in maize using a Caco-2 cell/ QTL 
model. As earlier mentioned, the alleles present in the maize population used in this 
research work may not represent the best alleles available for iron biofortification. 
Thus additional libraries should be screened for enhanced or diminished iron traits. In 
addition, studies on the effects of various postharvest treatments, cooking, and storage 
on grain iron nutrition retention should also be conducted. 
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Table 5.1: Summary of the research conducted and lessons learned. 
Study Research Question(s) Lessons Learned & Recommendations 
 
Study 1: 
Enhancing iron 
bioavailability in maize 
using a Caco-2 
cell/QTL model. 
 Is iron concentration in 
maize a genetically tractable 
trait? 
 
 Is iron bioavailability in 
maize a genetically tractable 
trait? 
 
Grain iron content and grain iron 
bioavailability can be genetically 
manipulated and enhanced through 
breeding. 
 
The better approach to iron 
biofortification in maize requires breeding 
for enhanced grain iron bioavailability 
relative to grain iron content. 
 
 
Study 2: 
Evaluating Genotype x 
Environment 
interaction in 
biofortified maize. 
 Does growing biofortified 
maize in diverse locations affect 
iron concentration and/or iron 
bioavailability in the maize 
lines? 
 
Genotype x Environment interaction has 
an effect on iron trait expression. 
 
Soil properties may also influence iron 
trait expression. 
 
Interdisciplinary research that includes 
soil scientists and agronomists is needed 
to better understand the soil effect. 
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Table 5.1 (Continued). 
Study Research Question(s) Lessons Learned & Recommendations 
 
Study 3: 
Assessment of iron 
bioavailability from 
iron biofortified maize. 
 
 Are significant differences 
in iron bioavailability as 
measured by the Caco-2 cell in 
vitro iron model reflected in an 
in vivo iron model? 
 
 
The Caco-2 cell bioassay and the poultry 
model showed similar results on iron 
bioavailability from the maize samples. 
 
Caco-2 cell bioassay is an effective tool 
for screening iron biofortified maize. 
 
Conventional breeding can improve iron 
nutritional quality in maize grain, thus 
providing significantly more bioavailable 
iron to growing chicks. 
 
Human feeding trials should be conducted 
to determine the efficacy
 
of consuming the 
high bioavailable iron maize. 
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Study 2: Evaluating Genotype x Environment interaction in biofortified maize. 
This study called attention to the soil effect on iron bioavailability in the grain. Figure 
5.2 presents data from a previous study by Hoekenga et al. that presented a similar 
point. 
As seen in Figure 5.2, maize lines from the IBM RI population were grown 
three times in New York (NY; 2001, 2003, 2005) and once in North Carolina (NC; 
2005) in replicated trials. What is striking about the data is that the grain iron 
concentrations for maize grown in NC was double that grown in NY, as shown by the 
median grain iron concentration numbers. The soil type in Aurora, NY was Lima silt 
series Loam (alfisol) with pH 6.7, while the soil type in Clayton, NC was Norfolk 
loamy series sand (ultisol) with pH 4.8. It is reasonable to assume that the low pH of 
the NC soils allowed the plants to assimilate more iron from the rhizosphere, which 
was then partly compartmentalized in the grain. The data thus suggest the need to 
include soil scientists in iron biofortification projects, with the goal of identifying and 
mapping soils in target regions that would be ideal for growing iron biofortified maize. 
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Figure 5.2: Grain iron concentration of maize grown in New York and North Carolina 
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Study 3: Assessment of iron bioavailability from iron biofortified maize. This 
study raises positive prospects for iron biofortified maize. It is clear that human 
feeding trials should be conducted to determine the efficacy
 
of consuming high 
bioavailable iron maize. Based on the amount of resources available and the research 
question raised, single-meal or long-term studies can be used to assess iron 
bioavailability in human subjects. This next step however raises two important study 
questions: 
Question 1. Long-term feeding trials are the definitive test for iron 
biofortified foods. These ideally work with mildly anemic or non-anemic subjects. 
However, if a long-term feeding trial is carried out in a malaria-endemic region, the 
‗iron trap‖ is brought into question. How can this be best addressed? 
The iron trap is defined as the interaction between increased intake of non-native 
iron (via iron supplementation or food fortification) and susceptibility to infectious 
diseases such as malaria (Friedman et al, 2009, Sazawal et al., 2006). The best 
approach if working in a malaria-endemic area would be to have procedures in place 
with which to closely monitor malaria, morbidity, and mortality and to have 
intermittent preventive treatment built into the efficacy trial. If the research goal is 
simply to show proof of concept, then an alternative approach would be to conduct the 
study in an area that is not classified by the Centers for Disease Control or the World 
Health Organization as a malaria-risk region. 
Question 2. If on the other hand a single-meal study is selected, does it 
matter whether extrinsic or intrinsic labeling is used? To better approximate iron 
bioavailability from foods, many assessment techniques have incorporated either 
radioisotopes or stable isotopes of iron into a meal. Intrinsic labeling of plants requires 
growing plants in nutrient media labeled with an iron isotope. In contrast, extrinsic 
labeling would involve adding iron isotope labels during preparation of test meals. The 
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extrinsic labeling technique is based on the assumption that complete isotopic 
exchange takes place between an extrinsically added iron isotope label and the native 
iron in the food so that the fractional absorption of the extrinsic label by human 
subjects predicts total iron absorption. Data presented in a study by Cook et al (1972) 
suggested that iron absorption from an intrinsic tag was very similar to that from an 
extrinsic tag. Welch et al. (2000) argue, however, that although extrinsic labeling of 
foods is easy and relatively inexpensive, poor equilibration of the extrinsic label would 
cast the results from such studies into question. Some studies that have compared 
intrinsic and extrinsic labeling in foods have questioned the use of extrinsic tags (Jin et 
al, 2008; Heaney et al, 2000). Research on the subject in the context of biofortified 
maize may be required to conclusively address this research issue. 
Last but not least, additional research is required to further refine model 
bioavailability systems used for screening iron biofortified crops. The Caco-2 cell in 
vitro iron model has been invaluable in screening maize lines in this study. However, 
to compare results from one experiment with those of another requires a control 
sample to be used in the all experiments so that the sample: control ratios can be 
compared. After careful thought, we decided to use Tamale maize grown and 
consumed in Mexico as a control sample in our research work. If not wisely selected, 
the control sample can be a limiting factor in the study, and this fact raises the issue of 
how best to select a control sample. Is it necessary to have a synthetic control sample 
in addition to a researcher‘s control sample? Further research should be dedicated to 
addressing these questions. 
The poultry model has been previously used to understand iron bioavailability, 
and shows promise as an initial in vivo screening tool for iron biofortified foods (Tako, 
Rutzke & Glahn, 2010). However, data and information about how to optimize the 
model for an iron bioavailability trial is limited to a certain extent. This is especially 
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true when we consider the extensive information available on the pig and rat models. 
It would thus be useful to devote further research to developing an iron bioavailability 
study protocol for the poultry model and establishing hematological indices to guide 
researchers as they conduct these studies. 
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